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Abstract
Hybrid materials have been found to be possessed with unique and novel properties, by su-
perimposing the advantages of each component to provide material properties far superior to
the individual constituents alone. These types of material are used throughout the field of bio-
engineering, and can facilitate biological interactions on both a molecular and cellular level,
responding to biological and mechanical queues. With these inherent unique properties these
materials provide novel platforms to help repair, replace and regenerate body tissues and func-
tion.
This thesis explores the synthesis of new “smart” hybrid hydrogels and their properties.
Through the conjugation of self-assembling b-sheet peptide sequences to a naturally occurring
poly (g-glutamic acid) polymer backbone, peptide-polymer hybrid hydrogels were formed. These
hybrid hydrogels were attributed with robust and tunable mechanical properties. Through the
reassembly of the physical b-sheet crosslinks the hydrogels can respond to their mechanical
environment, exhibiting “self-healing” capabilities and a resistance to cyclic strain. Also, being
composed entirely of natural peptide bonds they have excellent biocompatibility and are a
promising platform for future tissue engineering scaﬀolds and biomedical applications.
These hybrid hydrogels were further functionalised to detect for the activity of enzymatic
biomarkers. A simple assay based on Förster resonance energy transfer was incorporated in
to the hydrogel platform through the immobilisation of quantum dots modified with peptide
substrates. The activity of matrix metalloproteinase-7 was targeted specifically, a marker for
inflammation and immunity. This hydrogel sensing platform provides a basis for the in vivo
sensing of enzymes and also, the potential to be used as a powerful tool to investigate biological
processes in vitro.
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1.1 Introduction
Materials have been used to aid the practice of medicine for thousands of years by either as-
sisting with the body’s natural healing process or restoring lost tissue or organ function by
providing a functional equivalents. The health of the world’s increasing population has under-
gone an epidemiological switch in terms of disease burden. Communicable disease use to be
accountable for the highest proportion of mortality worldwide but it now has been replaced
by non-communicable disease, including conditions such as cardiovascular disease, respiratory
disease and cancer, which now accounts for 58.5% of global mortality, making it the largest
contributor. To help combat this shift, new biomaterials are required to help repair, replace
and regenerate body tissues and function. With an ever growing understanding of biological
structures and processes there exists a greater need for materials that are precisely engineered
to interact on a molecular and cellular level responding to biological and mechanical queues.
To be able to achieve this often requires the adoption of an interdisciplinary approach calling
on knowledge and scientific principles from biochemistry, molecular biology, medicine, materials
science, solid-state physics and engineering.
Self-assembly is ever present in nature, forming complex structural hierarchies across many
length scales which provide structures with incredible architecture and properties. Drawing on
this inspiration, these basic folding patterns have allowed for the emergence of self-assembled
peptide based hydrogels which have been shown to display a range of attractive properties
from “self-healing”, as injectable systems where gelation can be induced by physiological stimuli
and excellent biocompatibility, degradation into natural peptide units and easy incorporation
of bioactive epitopes. Peptide-polymer conjugates are widely used in tissue engineering appli-
cations, where the peptide sequences are included to bind to cells to elicit a specific biological
response, such as cell adhesion or receptor signaling. However, little research has been focused
on utilising the self-assembly of peptide sequences to guide the organisation of polymer networks
through non-covalent interactions. These self-assembled peptide-polymer hybrid hydrogels are
a new class of hydrogel platform, which aim to superimpose the advantages of both peptide and
polymer based hydrogels to provide systems with unique and novel properties. Combining the
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“self-healing” capabilities and stimuli responsivity of the peptide/protein components with the
tailorability from the polymer network, has the potential to provide exciting new platforms for
new tissue engineering and biomaterial applications.
Inorganic nanoparticles have received a great amount of interest due to their unique optical,
electrical and chemical properties, which are not apparent in their bulk states. The integration
of this nanoscale phenomena into functional devices provides the potential for systems with
unique properties that can be tailored towards new applications. Quantum Dots (QDs) are
semiconducting crystalline nanoparticles, they have inherently attractive size dependent optical
properties and with their nanoscale architecture, providing a large surface area to volume ratio
allows for the decoration of a high density of biological molecules. This combination of excellent
optical properties with environmental-responsive and specific biorecognition motifs has resulted
in these QD conjugates being used as a powerful tool in a variety of biological applications,
namely as biosensors for enzymes and cellular process. Enzymes regulate various aspects of
cell processes; they function in the extracellular environment of cells and are often secreted or
anchored to the cell surface. Enzyme dysfunction and irregular activity is often a product of a
disease state, therefore the ability to sense and quantitatively measure enzymatic activity is of
great importance. The combination of inorganic nanoparticles with polymeric hydrogel networks
has huge potential as new hybrid materials with additional functionality. The inclusion of QD
based biosensors into these networks, coupled with the advantages hydrogel networks bring in
terms of delivery and tunable properties can provide a powerful tool for the sensing of targeted
biological processes in vivo. In light of the potential for hybrid systems to provide additional
functionality and properties to hydrogel networks, this thesis aims to explore and develop new
hybrid hydrogels with properties that are sensitive to both their mechanical and biological
environment.
1.1.1 Scope of Thesis
This thesis explores the use and development of Poly (g-glutamic acid) (g-PGA), an anionic nat-
urally occurring homo-polyamide towards novel “Smart” hydrogel materials with “self-healing”
and sensing functionality. These new hydrogels have superior properties and functionality to
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what has been investigated before, being designed to respond to their surroundings and envi-
ronment. “Self-healing” materials are of great interest in biomaterials as they can combat the
mechanical anisotropy and nonlinearity associated with native tissues, and in the form of a hy-
drogel can be used as an injectable system. The incorporation of additional sensing capabilities
into hydrogel networks provides the potential for new sensing platforms to gain information of
in vivo processes and added functionality to implantable materials. The focus of this thesis is
centered around the development and properties of a new self-assembled b-sheet peptide hy-
brid hydrogel platform and then the incorporation of a bio-sensor into the hydrogel network for
matrix metalloproteinase-7 (MMP-7) , an enzyme biomarker for inflammation and infection.
Chapter 1 provides an overview of current hydrogel strategies and their compositions, pre-
senting their diﬀerent properties, functionalities and applications which they have been tailored
towards. QDs and their optical properties are also summarised, as well as representative exam-
ples in bio-sensing of enzymes and techniques of incorporation into hydrogel networks. Chapter
2 reviews g-PGA and its current applications. Being synthesised by a natural bacterial processes
the material properties and secondary structure are investigated, laying a foundation of under-
standing for work in later chapters. Chapter 3 describes the synthesis and subsequent properties
of a self-assembled b-sheet peptide-g-PGA hybrid hydrogel, the chapter details the mechanical
properties in terms of resistance to cyclic strain and “self-healing”, resulting from the organisa-
tion of polymer chains via the formation of b-sheet crosslinks. The secondary structure and its
cell viability following additional biomolecule functionalisation is also investigated. Following
on from the development of a new hydrogel platform, Chapter 4 demonstrates the ability to
build in additional functionality into this platform. A QD-peptide conjugate enzymatic assay
is developed for MMP-7, based on Förster resonance energy transfer (FRET) and then is im-
mobilised within the hybrid hydrogel network providing the capability to sense for the state of
inflammation and infection within an implanted scaﬀold. This suggests that the self-assembled
b-sheet peptide-g-PGA hybrid hydrogel platform developed has both an interesting set of inher-
ent properties and provides an excellent platform for additional functionality driving it towards
new applications in biomaterials.
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1.2 Hydrogels as Biomaterials
Polymers are currently the most widely used biomaterial and can be derived from either synthetic
or natural processes [19]. Naturally derived biopolymers from plant process typically include
materials such as cellulose, sodium alginate, silk, and natural rubbers. In contrast popular an-
imal derived biopolymers include collagen, glycosaminoglycans, heparin, and hyaluronic acid.
Synthetic polymers are created from a range of polymerisation reactions and can be specifically
tailored for virtually any biomaterial application based on molecular weight, crystallinity, pen-
dant group choice, or copolymerisation with other polymer systems [19] . Another advantage of
polymers is they can be engineered and fabricated to take a variety of forms and dimensions,
straddling the macro- to nano-scales which makes them a popular choice when considering tissue
engineering and biomaterial applications. Within the body, many native tissues undergo com-
plex loading cycles and have pronounced mechanical anisotropy and nonlinearity. For example
consider the meniscus in the knee joint which is a complex fibrocartilage composed of multi-
ple diﬀerent types of collagen and glycosaminoglycans acting as a shock absorber to redirect
a multitude of compressive forces, shear stresses, circumferentially directed forces and tensile
hoop stresses [20]. In almost all biomaterial applications, distinct mechanical properties are
required and in many cases, regardless of its chemical design, any implanted material or tissue
engineered construct will need to mimic or replicate the mechanical behavior of the native tissue
in order to find clinical success [21]. This idea of trying to mechanically match tissue structure
or add robustness to a biomaterial is never easy, and with polymers having an inherent con-
trol of structure and tailorability of chemical composition makes them ideal candidates for such
applications.
One type of popular polymer based biomaterial are hydrogels, which have been applied as
fundamental components in a variety of biomaterial and therapeutic applications. They can be
defined as water-swollen polymeric materials which adopt and can maintain a distinct three-
dimensional structure [22, 5, 23]. Typically they consist of a hydrophilic polymer network which
is then cross-linked either chemically or physically to prevent dissolution. Water can penetrate
inbetween the polymer chains, subsequently causing swelling and the formation of a hydrogel
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structure. Having a large water content means most hydrogel structures will innately possess
excellent biocompatibility and being formed from polymeric networks results in a fine control over
composition [24]. Depending on their composition, hydrogels can be classified into many diﬀerent
types either by source (natural, synthetic or hybrid), crosslinking (covalent or physical), physical
structure (homogenous, microporous or macroporous) or their fate in the organism (degradable
or non-degradable). With such a diverse variety of design options for hydrogel composition,
hydrogels can be synthesised to adopt a range of diﬀerent structures and mechanical properties,
and by simple modifications can allow for the incorporation of biomolecules such as cell receptor
ligands and growth factors. This allows hydrogels to be tailored towards any biomaterial or drug
delivery platform, as well as microfluidics and nanotechnology [24].
1.2.1 Synthetic Hydrogels
Hydrophilic polymer networks can be synthesised by various synthetic polymerisation strategies
with molecular control over the entire structure such as molecular weight, degree of branching
and crosslinking density; this allows for the tailorability of other desirable properties such as
biodegradation, mechanical stiﬀness, and most importantly its chemical and biological response
to physiological conditions. Common synthetic polymers used to form hydrogels are poly (hy-
droxyethyl methacrylate) (PHEMA), poly (ethylene glycol) (PEG), and poly (vinyl alcohol)
(PVA).
PEG is widely used for many biomedical applications and been extensively studied, as it is
bioinert and available in a wide range of molecular weights and degrees of crystallinity. PEG
hydrogels have been found to be nontoxic, non-immunogenic and therefore, are approved by
the FDA for use in clinic. They have been covalently crosslinked by a variety of strategies
to form hydrogels, most notably via photopolymerisation with acrylate-terminated monomers
such as PEG diacrylate, PEG dimethacrylate, and multiarm PEGs. In a cellular environment
PEG is a passive constituent as they are inert to most biological molecules and prevent the
absorption of proteins, so although they can be readily made to form hydrogels they often
require further biological functionalisation. In light of this, they then have to be conjugated with
various peptide sequences to help promote cell adhesion [25] and cell receptor binding [26, 27] to
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name a few. Another disadvantage of PEG hydrogels is they are not naturally degradable and
have to be modified to incorporate degradable segments. Many strategies have been developed
to help promote degradation, including the copolymerisation with degradable poly(ethylene
oxide) or poly(lactic acid) [28] and other modification such as with polyester [29], poly(propylene
fumarate) [30, 31], acetal [32] and disulfide [33]. PHEMA is another polymer which is widely used
and studied to form hydrogel networks for biomedical applications. Due to its attractive features
in terms of mechanical properties and optical transparency, it has been a popular material for
contact lenses [34, 35]. Similarly to PEG hydrogels, its mechanical, swelling and degradation
properties can be easily tailored as well by copolymerisation with diﬀerent monomers. Another
major synthetic polymer used to form hydrogels is PVA. It can be crosslinked both physically
and by covalent methods, however physically crosslinking is preferred as it renders a degradable
hydrogel. PVA has been crosslinked chemically via a variety of difunctional crosslinking agents
and via photocrosslinkable strategies [24].
1.2.2 Naturally Derived Hydrogels
Hydrogels made from natural sources can be derived from polymer such as collagen, hyaluronic
acid (HA), fibrin, alginate, agarose and chitosan, and have many advantages over the synthetic
hydrolytically degradable hydrogels previously discussed. Most of the naturally occurring poly-
mers are derived from various components of the mammalian extracellular matrix (ECM) , and
therefore have advantages especially in terms of bioactivity, they are also typically enzymati-
cally degradable, degrading into naturally occurring units and also have the ability to incorporate
receptor binding ligands to cells, are susceptibly to cell-triggered proteolytic degradation and
undergo natural remodeling [19].
Collagen is the most abundant protein present in the human body, it is a major component
of skin and other musculoskeletal tissues [36, 37]. There are several diﬀerent forms of collagen
found in the body, each being made up of diﬀerent sequences of amino acids. Collagen undergoes
degradation via enzymes such as collagenases and metalloproteinases, and has unique mechanical
and biological properties, containing many cell-signaling domains present in the ECM. Collagen
hydrogels are typically crosslinked for improved mechanical properties with various strategies
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which have been investigated such as chemical covalent crosslinking [38], with UV or temperature
[39] and also through other polymeric domains [40].
Polysaccharides are macromolecules formed from many monosaccharide units joined together
by glycosidic linkages and are thought to have unique biological functions in regards to cell
process, including signaling and immune recognition [19], and playing an important part of
wound healing process [41]. Polysaccharides derived from human origins include HA which
is a glycosaminoglycan (GAG) . HA degrades via hyaluronidases and has been successfully
crosslinked by chemical modifications to form hydrogels. Hydrogels composed of HA have been
engineered for the controlled release of bone morphogenic protein 2 (BMP-2) and also has
combined with other GAG molecules to develop an injectable system for the delivery of fibroblast
growth factors [42]. Polysaccharides of non-human origin, which have been used as hydrogels are
chitosan and alginate, which are derived from crustacean skeletons and brown algae, respectively.
Dissolved chitosan can be simply crosslinked by pH, photocrosslinking and chemically to form
hydrogels for many applications. It can also be degraded by the lysosome and therefore be
degraded in humans. Alginate has also been an attractive base for hydrogels, it is a linear
polysaccharide with a high acid content, which allows it to gel under benign conditions most
notably with divalent cations such as Ca2+ which form a an ionic bridge between polymer chains.
This makes them attractive for the encapsulation of biomolecules and cells [43, 44]. However,
alginates have poor degradability, as they are not able to undergo enzymatic degradation in
mammals, so they require further chemical modification to allow for hydrolytic degradation [45]
which then can be controlled by the monomer units and molecular weight of the polymer, but
even then it can be a slow process.
Poly (amino acids) are another type of enzymatically degradable polymers, they are ionic and
are derived from one type of amino acid, they include polymers such as cyanophycin, poly (e-L-
lysine) (PLL) , g-PGA and poly (L-glutamic acid) (L-PGA). These polymers contain carboxylic
and amino groups that can be utilised for crosslinking into hydrogels or modified to improve
their functionality making them promising candidates for hydrogels, tissue engineering scaﬀolds
and drug delivery [19]. PLL and g-PGA are both of bacterial origin, and PLL is known to have
antibacterial, antiviral and anti-tumor activity. PLL and L-PGA have been combined with other
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polyamino acids and gelatin to form hydrogels [46, 47, 48]. g-PGA and its derivatives will be
discussed in great detail in following chapters.
1.3 Self-Assembly of Peptides
Self-assembly in its broadest sense is the spontaneous association and organisation of multiple
individual units into rational and defined structures without the need of any external partici-
pation, it is present in many parts of nature on both macro- and micro-scales [49, 50, 51, 52].
Molecular self-assembly can be recognised as the specific association of molecules through non-
covalent interactions, including hydrogen and ionic bonds, and hydrophobic and van der Waals
interactions [50]. Individually, such interactions are weak, but if they occur in large numbers the
collective interactions can dominate the structural and conformational behaviour of the assembly
forming stable hierarchical structures [50]. To form structures through molecular self-assembly,
the key is to design building blocks that are both chemically complementary and compatible
structurally, taking into account size and orientation like chirality [50].
Nature is considered to be the master of designing constituents for molecular self-assembly,
and ultimately through evolution has produced systems of greater and greater molecular ar-
chitectural complexity. A range of complex macromolecules, macromolecular complexes and
structural materials found althrough nature include silks, collagen, bones and teeth which all
display the self-assembly of building blocks [53]. These structures are often a combination of
self-assembly at diﬀerent length scales, take for example a collagen fibre which results from the
hierarchical organisation from the nanoscale to macro-scale. Three collagen macromolecules
form a single triple helix, multiple triple helices then assemble into fibrils which then in turn
align to form a single collagen fibre [54]. Collagen is part of a super family of abundant na-
tive proteins, which all consist of a series of basic folding patterns that when combined have
the power to self-assemble and form complex structural arrangements. Recognising which in-
teractions of biological building blocks and peptide structural motifs present in native proteins
that are responsible for these structural folding patterns has led to the ability to design and
build new molecular biological materials through the self-assembly of relatively short peptide
29
sequences. Folding patterns of native proteins exploited to form these materials include b-sheets
anda-helices.
1.3.1 b-sheet Hydrogels
b-sheets are one of the major structural elements present in proteins, b-strands align adjacent
to each other and are stabilised via hydrogen bonds that form between the carbonyl oxygen of
one amino acid and a backbone amide of a second amino acid on an adjacent strand. b-sheets
are formed of at least two strands but it is common for more strands to be present, assembling
into arrangements that are either parallel or antiparallel (Figure 1.1) [5, 53, 55, 50]. Diﬀerent
amino acids have diﬀerent propensities to form b-sheets depending on their conformational
preferences, which results in the stability of an individual b-sheets being dependent on the
interactions between side chains of neighbouring amino acids. b-sheet forming peptides have
been found to have a huge biological relevance, where amyloid type fibres formed from the
misfolding of proteins into b-sheets have proven to be a major contributor in Alzheimer’s disease
pathogenesis and Parkinsons disease [56, 57, 58]. However, the formation of amyloid type fibres
has inspired the design of similar structures from short self-assembling peptides that can be
used as biomaterials. Despite the fact that amyloid aggregates are known to have toxicity issue
with living cells, the formation of synthetic amyloid-inspired materials have been found to not
be cytotoxic [59].
Figure 1.1: Parallel and antiparallel b-sheet conformations.
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1.3.1.1 Amphiphilic b-sheet Peptide Hydrogels
The design of structures from b-sheet self-assembling peptides typically involve the use of am-
phiphilic peptide sequences which form well ordered nanofibres. These have alternating amino
acid residues that generate two distinctive sides, one being hydrophobic and the other hy-
drophilic. The hydrophobic side forms a b-sheet core inside the fibre whilst the hydrophilic
side is presented on the outside of the nanofibres (Figure 1.2A). The hydrophilic outer core can
interact freely with water molecules, and the entanglement of the network of fibril results in
the formation of a high water content hydrogels [1, 60, 61, 62, 63, 64, 65, 66, 67]. It has also
been demonstrated that by altering the length, concentration and charge of the self-assembling
peptide sequences, the gelation and properties of the hydrogels can be tuned and manipulated
into functional biomaterials [67, 68]. Hydrogels only form from these types of amphiphile when
the fibril density is suﬃcient to cause enough entanglement to retain water. Changing the pep-
tide sequence by simply altering the length of the peptide sequence or by adding extra charged
residues to the hydrophilic side, gelation can be controlled by external stimuli such as pH or the
addition of ionic salts. Being able to control the gelation through simple stimuli and the excel-
lent biocompatibility associated with these hydrogels has led to them being used as a 3D matrix
in a variety of applications, including a template for neurite outgrowth [69, 70], to promote
angiogenesis [71], for the delivery and release of functional proteins [72, 73] and as an injectable
scaﬀold for cell delivery and repair [74, 75, 76, 77].
1.3.1.2 b-hairpin Hydrogels
Another b-sheet based assembly used to form hydrogels is the b-hairpin motif, comprised of two
adjacent antiparallel b-strands joined by a b-turn promoter (VDPPT) which after intramolecular
folding and intermolecular assembly forms b-sheet bilayer fibrils, and when driven by external
stimuli can readily form hydrogels (Figure 1.2B) [78]. Typically the two b-strands have a similar
amphiphilic design to the peptides previously mentioned, so hydrogel formation occurs again
through fibril entanglement and can be triggered by external stimuli such as pH, ionic strength
or temperature [78, 79, 80, 81, 82]. For example, the MAX1 peptide, ((VK)4-VDPPT- (KV)4-
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CONH2), consisting of two strands of alternating K and V residues connected by a tetrapeptide
turn sequence [78, 83, 84]. Its folding into a b-hairpin is initiated by an increase in pH or in
ionic strength [78, 80], and it has also been demonstrated that the mechanical properties of these
hydrogels are dependent on the same factors. Hydrogels derived from the MAX1 peptide and its
variants, have been used in a wide range of applications including injectable shear-responsive 3D
tissue culture matrices [85, 86, 87, 88, 89, 90], antibacterial gels [91] and drug delivery materials
[92]. Using these peptide sequences, the eﬀect of additional charge residues on the hydrophobic
face of the b-sheet on self-assembly and hydrogelation was investigated, and it was found that,
for example, the addition of a threonine residue for a valine residue reduced peptide self-assembly
proportionally to the number of replaced residues. In general, the introduction of polar residues
to the hydrophobic side of the these peptide sequences had a negative eﬀect on the self assembly
and hydrogelation [87, 79]. In contrast, the addition of charged residues to the hydrophilic face
of MAX1 had a positive eﬀect [2, 86]. Selective lysine for glutamic acid (Glu) replacements
resulted in an increased propensity to self-assemble and stabilisation of b-hairpin folding by Lys-
Glu interactions. The eﬀects of empirically correlating specific amino acid modification and its
resultant eﬀect on hydrogelation behavior was an interesting study, but the molecular basis for
the relationship between self-assembly and hydrogelation is still mysterious [56].
1.3.1.3 Non-amphipathic b-sheet Peptide Hydrogels
Importantly, the formation and self-assembly from single peptide to amyloid fibre was also inves-
tigated using a series of short model linear peptides [93, 94], which were non-amphipathic and
strategically incorporated with arginine (Arg) and Glu residues to induce the favorable formation
of antiparallel b-sheets through coulombic interactions [3]. Aggeli et al showed through molecular
dynamic simulations that the structure of the assembly of the sequence Ac- QQRQQQQQEQQ-
NH2 was dependent on the concentration of the peptide, assembling from ribbons to fibrils at
higher concentrations (Figure 1.2C). At lower concentrations the hydrogen bonding between
Glutamine (Gln) residues in the b-strands were shown to be highly twisted, preventing the
formation of longer fibrils [95]. Being non amphipathic allowed these sequences to be further
modified to create increased b-sheet self-assembly propensity. The Gln residues at points of the
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base peptide were replaced with the hydrophobic residues phenylalanine (Phe) and Tryptophan
(Trp) that can participate in p-p interactions within the b-sheet bilayer, promoting the formation
of helical tapes and larger assemblies [3, 94]. In fact, this increased hydrophobicity of the based
peptide led to the formation of micron long fibrils compared with the shorter fibrils formed by
the Ac-QQRQQQQQEQQ-NH2 sequence alone. The more hydrophobic peptide also displayed a
similar concentration dependent relationship to fibril formation, however at larger concentration
actually formed a hydrogel [96]. Further molecular dynamics studies implied the increased fibril
length inherent of the more hydrophobic residues, resulted in the interactions between aromatic
groups stabilising b-sheet bilayer formation [95]. The pH sensitivity of these model peptides
were also studied, for the base peptide the amino acids on the hydrophilic face were found to
be the factor that dictated pH sensitivity [97]. However, the hydrophobic modified peptide was
found to not be sensitive to pH since the replaced residues prevent any charge repulsion with
the aligned Arg. Further work proved that by replacing and aligning residues at diﬀerent points
along the peptide sequence to evoke charge repulsion, the hydrogelation and assembly could be
controlled finely by pH [97]. Using these class of short non amphipathic model linear peptides,
peptide hydrogels have been used as three dimensional cell culture scaﬀolds [98, 53] and through
additional residues at the N- and C-termini the hydrogel rigidity can be tuned [99].
1.3.1.4 Peptide-amphiphile b-sheet Hydrogels
b-sheet based hydrogels have not only been limited entirely to being formed from peptide residues
alone. Namely, the Stupp group have pioneered the peptide-amphiphile (PA) ; this is composed
of a long hydrophobic alkyl tail, followed by a short b-sheet peptide sequence that is capable
of forming hydrogen bonds with neighbouring PAs and in the final region contains negatively
charged amino acids that help promote water solubility and allow for assembly to be induced
by pH and the addition of salts [100]. The advantage to this design is that PAs pack to form
high aspect ratio nanofibres, in which the hydrophobic alkyl tails form the core of the fibre,
presenting a very high density of peptide residues on the outside of the fibre (Figure 1.2D)
[100, 4, 101, 102]. This allows for the engineering of diﬀerent types of short bioactive epitopes
on the nanofibre surfaces, which can be easily synthesised along with the rest of the PA. Typical
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epitopes incorporated are peptide sequences that promote cell adhesion such as the RGDS
peptide [103, 4, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117] and the
laminin-derived IKVAV which is a peptide sequence thought to be crucial for cell attachment,
migration, and neurite outgrowth [118]. The IKVAV epitope has been specifically incorporated
into PAs as a bioactive sequence for neural applications [119, 104, 120]. Furthermore, the third
region usually comprised of negatively charged amino acids, can be engineered to trigger the
growth of nanofibres by the addition of salts or by changing solution pH. Having a system
which can be engineered to be responsive to pH or salts is critical for developing injectable
materials as gelation/assembly can be tuned by the introduction of multivalent ions present in
physiological media. This allows for the easy encapsulation of cells, providing a 3D nanofibre
matrix [106] and coupled with the ability to easily include a combination of biological epitopes,
it acts as a perfect cell culture scaﬀold to investigate potential signaling pathways [121, 114].
Also, properties such as gelation time and stiﬀness [122, 123] of PA hydrogels can be tuned by
the alteration or inclusion of hydrophobic/hydrophilic residues in the second domain. This is
considered important for the tailoring of these injectable systems towards diﬀerent applications,
as diﬀerent cell types have been shown to be responsive to diﬀerent mechanical environments
[124].
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Figure 1.2: Examples of self-assembled b-sheet hydrogels. A), i) AEAK16-1 and RADA16-1
amphiphilic b-sheet peptide sequences, ii) Formation of the RADA16-1 into a nanofibre adapted
from [1]. B), i) MAX1 and MAX8 b-hairpin peptide sequences, ii) Schematic of the formation
of b-hairpin peptide hydrogels adapted from [2]. C) i) Examples of short non-amphipathic
b-sheet peptide sequences and ii) Diﬀerent assembly states of the P11-1peptide with increasing
concentration, adapted from [3]. D) i) Peptide-amphiphile b-sheet peptide design and ii) Peptide-
amphiphile assembly in a nanofibre, both adapted from [4].
1.3.2 a-Helices
Another basic folding pattern of proteins utilised to assemble into biomaterials is the a-helix.
Unlike b-sheet amyloid fibre based assemblies comprised of many b-strands which pack together
35
to form higher order tertiary and quaternary structures, a-helices are largely self-contained
hydrogen-bonded networks where the backbone hydrogen bonding is largely satisfied within the
present structure and therefore, has less potential to form higher-order interactions [6]. However,
controlling the self-assembly of b-structures is diﬃcult and yet to be fully understood, whereas
the assembly of a-helices is more contained, and as a result have much more defined rules apply to
control assembly [6]. The formation of helix-helix assemblies is controlled by discrete side-chain
interactions between neighbouring helices and most designs have well defined peptide sequences,
in which assembly is drawn directly from protein folding interactions. ↵-helix based assemblies
include coiled-coils and collagen mimetic peptides.
1.3.2.1 Coiled-coils
Coiled-coils are composed of two or more right-handed ↵-helices winding together to form a
slightly left-handed super helix. The primary structure of ↵-helices has an average of 3.6 residues
per turn that results in runs of hydrophobic residues being spaced three or four residues apart
with polar residues inbetween giving an overall amphipathic structure. When the pattern is
designed to be regular and repeated, the coiled-coil motif can be characterised by a sequence
of repeating heptads designated with [a, b, c, d, e, f, g]x, in which a and d are usually the
hydrophobic amino acid residues, and b, c, e, f and g are the intervening polar residues (Figure
1.3A). Hydrophobic interface between a and d, make b, c, and f faces outward and electrostatic
interactions between residues e and g contribute to the overall stability of the coiled-coil. De-
pending on their detailed structure, ↵-helices can associate into homodimers and heterodimers
both in parallel or antiparallel alignments, or more interestingly can form higher order structures
like tetramer type aggregates (Figure 1.3A).
The first ↵-helical peptide based assemblies were designed to be made from single peptide
components and were found to form fibrils of 5-10 nm thickness and several microns in length
[125]. The mechanism behind the fibril formation is thought to stem from the hydrophobic
faces of the amphipathic helices slipping and oﬀsetting to generate a staggered assembly. Fol-
lowing the idea to use the staggering of helices to generate longitudinal growth of assemblies,
single component ↵-helices were designed to include sequences to promote inter-helix electro-
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static, charge-charge interactions, and hydrogen bonding in an attempt to induce staggering and
longitudinal growth (Figures 1.3B and C) [126, 127]. More uniquely, oﬀset dimers have been
designed to be set completely out of phase within a single peptide resulting in two halves that
can only interact intermolecularly and not intramolecularly (Figures 1.3D) [128]. By design, the
assemblies were expected to extend longitudinally, but it was also discovered that the fibres can
thicken to form bundles and rods [129]. It was realised that the lateral packing of the fibrils
is caused by fibril-fibril interactions, and is aﬀected by features on the outside of the coil-coil
units, so individual peptide sequences can be designed to promote thickening and ordering of
the assemblies [6, 128]. However, introducing charged residues in the outer b, c and f sites was
found to be detrimental to lateral packing and caused thinning [130].
Peptide coiled-coil assemblies are not only limited to single component peptide interactions;
several systems exist that are made from heterodimeric peptides. Most notably the complemen-
tary leucine-zipper sequences formulated from IPPLPPP heptad repeats and similarly to the
latter single component systems, the assembly is designed to be oﬀset with terminal ends that
help induce longitudinal growth (Figure 1.3E). These peptides were rationally designed to have
positively charged N-termini and negatively charged C-termini, so when oﬀset the overhangs will
have an aﬃnity for each other. Using these rationally designed sequences has allowed them to be
used as building blocks to formulate much larger designed assemblies and architectures (Figure
1.3E), such as branched [131], kinked [132], crossed-linked fibres [133] and other morphologies
[134]. With a greater control over assembly design using these multicomponent systems, the
fibre surfaces have been functionalised with fluorophores [135] and for bio applications peptides
and functional proteins [136].
The field of peptide based hydrogels has been mostly dominated by the b-sheet amyloid
type structures previously mentioned, although in a few cases short a-helical coiled-coil peptides
have been shown to form hydrogels at low and neutral pH, although at relatively high peptide
concentrations (Figures 1.3F and 1.3G) [7, 8]. Also, temperature responsive hydrogels have
been made from a-helical assemblies by replacing all of the outer b, c, and f positions with
Ala residues. In all cases gelation is caused by the formation of an interconnected networks of
thin a-helical fibrils. Helical based hydrogels have shown to be promising, having advantages in
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terms of responsive behaviour, but have quite a way to go especially in terms of their mechanical
properties before they rival that of the b-sheet amyloid structures previously discussed.
Figure 1.3: A) Structure of coiled-coils, reproduced from [5]. Examples of strategies for higher
order assemblies of coiled-coils B) Slipped assembly, C) Sticky end assembly D) Sticky ended
leucine-zipper assembly, and E) Out-of-phase hydrophobic faces assembly, all reproduced from
[6]. Examples of coiled-coil self-assembled hydrogels, F) i) Schematic of self-assembled coiled-
coil nanofibres, ii) Images of hydrogel formation and iii) TEM image of coiled-coil nanofibres,
reproduced from [7], and G) Responsive a-helical peptide hydrogels. i) Schematic of designed
interactions between coiled-coils and ii) - v) Cryo-SEM of coiled-coil network formation (all
images at same magnification) reproduced from [8].
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1.3.2.2 Collagen Mimetic Peptides
One of the most abundant proteins in the body is collagen, forming large portions of the ECM
and providing support to many tissues in the body [37]. Within the body, there are many
diﬀerent forms of collagen, found in a variety of diﬀerent tissue types which can adopt diﬀer-
ent supramolecular structure such as sheets, fibrils and fibres, depending on their functional
requirements [36]. Despite forming a variety of structures, they all consist of a common domain
known as the collagen triple helix, which is formed by a polypeptide chains that adopt a left-
handed type II polyproline helix conformation, and in turn wrap around each other to form a
tightly packed right-handed super-helix. Collagens can be either homotrimers, made from three
identical sequences (AAA) or heterotrimers that include two specific sequences (AAB) or finally
heterotrimers made from three distinct sequences (ABC) [9]. The assembly of collagen is of great
interest because it has the ability to adopt a wide range of supramolecular structures, which
could be utilised in many biomaterial applications mimicking major aspects of the ECM [137].
To date there has been limited success in turning triple helical peptides into large supramolec-
ular structures, with most work been focused around gaining knowledge on the structure and
stabilisation of the triple helix folding motif from the synthesis of short model peptides.
The primary structure of a triple helix contains a three amino acid repeat requiring a glycine
(Gly) as every third amino acid (X-Y-Gly). Each of the three component chains adopt a polypro-
line type II left handed helix, associating with the two other chains via a hydrogen-bonding net-
work and van der Waals interactions, along the backbone of the polypeptide chain. Hydrogen
bonds occur between the carbonyl group of the amino acid in the X position in one chain and
the amide nitrogen of glycine in a diﬀerent chain (Figure 1.4B). This allows for tight packing of
the chains, maximising the contact area for van der Waals interactions; glycine, being the third
amino acid in every triplet, is always facing towards the core of the helix (Figure 1.4C). This
results in the chains assembling oﬀset by a single amino acid in a staggered manner, resulting
in there always being a glycine residue in every cross-section of the helix perpendicular to the
helical axis [9].
Designing peptides sequences that can replicate the triple helix structure of collagen is dif-
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ficult, especially heterotrimeric assemblies which suﬀer from the competition of sequences and
the registering of the individual chains when multiple components exist. The first successful
self-assembled heterotrimers were of the AAB variety, formed from a mixture of (POG)10 (Fig-
ure 1.4A) and (PPG)10 peptides, however little control over the composition of the assemblies
was typical [138] and other early systems suﬀered from a low thermal stability [139]. To combat
these stability and composition problems, oppositely charged amino acids were investigated to
drive the self-assembly of heterotrimeric systems. These were composed by a mixture of three
diﬀerent peptide sequences, one positively charged (PKG)10, one negatively charged (EOG)10
and a neutral peptide (POG)10, which self-assemble to form a zwitterionic ABC triple helix
(Figure 1.4D) and with the desired (PKG)10-(EOG)10-(POG)10 heterotrimer verified by NMR
experiments [140, 141] . The design of the peptides were based on the sequences found in nat-
ural collagen in which the positive amino acid is in the Y position of the (X-Y-Gly)n triplet
and the negative amino acid in the X position. Driving the self-assembly of heterotrimeric
assemblies through electrostatic interactions has also been adopted to control the composition
and register of AAB heterotrimers. This was achieved by mixing two negatively charged pep-
tides (EOGPOG)5 sequences with one positively charged (PRG)10 sequence, resulting in the
formation of a zwitterionic AAB triple helix (Figure 1.4D) [142].
Developing higher order assemblies of collagen mimetic triple helical assemblies into nanofi-
bres and fundamentally then into hydrogels is considered to be the greatest obstacle in this area
of research. In native collagen itself, five triple helices pack together in a quasi-hexagonal lat-
tice to form fibrils and then can further self-assemble both axially and laterally to form mature
collagen fibres [143]. Over time it has been shown that homotrimeric POG based sequences will
aggregate together but with little control of this aggregation, prevents it from mimicking the
hierarchical assembly of natural collagen [144]. Several approaches have been used to produce
higher order assemblies and the formation of nanofibres, notably the addition of hydrophobic
residues at the termini of the sequences has yielded the assembly of nanofibres in multiple sys-
tems [145, 146]. Alternatively, cysteine has been used to form a covalent link between triple
helices [147] and also, a combination of cysteine residues along with thioesters has been used
instead of disulfide bonds to drive polymerisation, forming uniform nanofibres [148]. Similarly to
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the a-helical higher order assemblies previously described, sticky-end motifs have been included
into the (PRG)4(POG)4(EOG)4 peptide sequence so that at physiological pH, the positively
charged Arg N-terminus would form electrostatic interactions with the negatively charged Glu
C-terminal region [149] and was able to successfully form nanofibres. Based on this system,
the peptide sequence was changed, Arg residues were replaced with Lys and Glu residues were
replaced with Asp to give the sequence of (PKG)4(POG)4(DOG)4 . The more eﬀective inter-
actions between the replaced residues resulted in superior fibre assembly and the formation of
hydrogels (Figure 1.3E) with good viscoelastic properties [10].
Figure 1.4: Triple helix structures. A) (POG)10 structural model, B) Network of hydrogen
bonding, C) Glycine interactions at triple helix core, and D) Assembly of heterotrimeric collagen
mimetic peptides of ABC and AAB composition, all reproduced from [9]. E) Self-assembled
collagen mimetic peptide hydrogel, reproduced from [10].
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1.3.3 Self-Assembled Protein/Peptide-Polymer Hybrid Biomaterials
Peptide self-assembly can be used to direct and guide the organisation of polymer networks
to form hydrogels and other 3-dimensional structures via the use of recognition motifs. This
approach utilises the stimuli responsivity of certain peptides/proteins to drive the formation of
non-covalent interactions forming an interconnected network of macromolecules. Depending on
which type of peptide recognition sequence and its aﬃnity governs the arrangement of the poly-
mer network into a 3-dimensional structure. The most recent examples of hybrid systems are
composed of a synthetic or natural polymeric network which is then connected by either a peptide
or protein recognition motif. These types of hybrid materials are of great interest because they
have the potential to provide properties far superior to those of the individual components alone.
Superimposing the advantage of the stimuli responsivity of the peptide/protein components and
the tailorability of the polymer network, both in biocompatibility and mechanical properties,
provide new materials with unique organisations and novel properties. Peptide/Protein mo-
tifs used to form these types of hybrid material include b-sheet, ↵-helix and simuli responsive
proteins, and are discussed below.
1.3.3.1 b-sheet Peptide-Polymer Hybrids
b-sheet self-assembling peptide sequences have been combined with polymeric networks in two
ways to form hybrid networks. The first approach utilises hybrid block copolymers consisting
of polymeric and b-sheet domains [150, 151, 152, 153, 154, 155, 156]. In the first investigations,
copolymers of PEG and short b-sheet forming peptides were synthesised, in which PEGmolecules
were attached to the C-terminus of a 15 residue amyloid peptide [151, 150]. This network was
able to form reversible fibrils and was found to be composed of up to 6 laminated parallel b-
sheets surrounded by a PEG block. In a similar approach Börner et al, showed that PEG-b-sheet
peptide conjugates could self-assemble into tape like structures [157] and Klok et al, synthesised
b-strand peptide sequences that were flanked by either one or two PEG chains [155, 154]. These
amphiphilic block copolymers were found to stabilise the b-strand peptide secondary structure
and have reduced sensitivity to changes in pH, due to the steric hinderance caused by the PEG
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flanks following self-assembly and this prevents disassociation. A diﬀerent poly (HPMA) (2 and
5 kDa) polymer network was conjugated with a QQRFQWQFEQQ-NH2 peptide via a thiol-
maleimide coupling reaction to form a diblock copolymer[156]. These again had the ability
to self-assemble to form fibrils and similarly, the pH of b-sheet formation was diﬀerent for free
peptide than polymer conjugate, again highlighting that a polymer chain has an eﬀect on b-sheet
self-assembly.
The second approach involves the conjugation of b-sheet side chains grafted to a polymer
backbone [158, 11]. In the two cases investigated a HPMA polymer backbone was functionalised
with the b-sheet peptide sequence GCCTTRFTWTFTTT this sequence includes a GCC spacer
that allows the peptide to be conjugated to pendant maleimide groups present on a modified
HPMA polymer network [158]. It was shown via circular dichroism (CD) that the peptide-
polymer hybrid still had the ability to self-assemble into b-sheets, and had the same stabilising
eﬀect experienced with the previous b-sheet copolymers, where the hybrid material had less
sensitivity to temperature and pH. The peptide was designed to form antiparallel b-sheets and
this arrangement was maintained in the hybrid network being confirmed by FTIR. However,
the mechanical properties of these hybrid structures were investigated only by micro-rheology
and found to be relatively poor, barely forming hydrogel networks. Finally, taking this hy-
brid hydrogel platform, complementary b-sheet peptide sequences (TTRFTWTFTTT-NH2 and
TTEFTWTFETT-NH2) were grafted to the poly(HPMA) to the network, along with an addi-
tional RGDS peptide sequence. This hybrid network was explored as a scaﬀold for bone tissue
engineering, providing support for pre-osteoblast cells and displaying long term viability and
proliferation [11] (Figure 1.5A). It was suggested that the b-sheet fibrillar cross-links provided
surfaces that favoured hydroxyapatite-like crystal nucleation and growth. Mechanically these
hybrid hydrogels were found to have stiﬀnesses in the range of 100-400 Pa depending on their
composition and concentration. So far the previous work that has explored the formation of
b-sheet peptide-polymer hybrids has given encouraging results, but is yet to capatilise on the
potential benefits associated with b-sheet self-assembly both in terms of stimuli guided assembly
and the unique mechanical properties associated with physical crosslinks such as “self-healing”.
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1.3.3.2 ↵-Helical Peptide-Polymer Hybrids
↵-helical peptide have also been conjugated to polymer networks similarly to b-sheet peptide-
polymer hybrids in an attempt to organise polymeric networks. They have been combined with
polymeric networks both as hybrid block copolymers [159, 160, 161] and as grafts to polymer
backbones [162, 12]. For the first case, triblock ABA copolymers have been synthesised in which
the central block is composed from PEG flanked by two blocks of a peptide from the coiled-coil
region of fibrin. This triblock copolymer was found to self-assemble into hydrogels but dissolved
in buﬀer after 8 days [159]. Similarly, Sahin et al synthesised a multiblock polymer composed
of alternating PEG and coiled-coil forming domains, which formed heterooligomeric assemblies
and also, formed homooligomeric micellar structures [160]. Maleimide terminated 8-arm PEG
polymers have been conjugated with collagen mimetic triple-helix-forming peptides to again
form hydrogels [161].
↵-helical peptides motifs have also been conjugated to HPMA polymer backbones again in
a similar manner to the b-sheet peptide-polymer hybrids. The first of which utilised a homod-
imer ↵-helical peptide, which upon assembly of the coiled-coils formed hydrogels [162]. The
properties of these ↵-helical peptide-polymer hybrids were found to be mostly dominated by
the assembly of the coiled-coil motif, in which temperature-induced hydrogel collapse occurred
at an almost identical temperature to the coiled-coil structural transition from an elongated
helix to unfolded state. More recently, a pair of sequences which form antiparallel coiled-coil
heterodimers were grafted to a similar HPMA polymer backbone [12] (Figure 1.5B). The pep-
tide pair were designed to be pentaheptad sequences with an opposite charge, minimising the
probability of forming homodimers by charge repulsion. These hybrid networks spontaneously
self-assembled into hydrogels and maintained this morphology even at low concentrations. When
individual peptide sequences were grafted to the network the resultant secondary structure pos-
sessed predominantly a random-coil formation.
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1.3.3.3 Protein-Polymer Hybrids
Hybrid networks that are conjugated with proteins which can undergo conformational changes
when subjected to a given external stimuli have the potential to be used in a variety of biomate-
rial applications. The calcium binding protein calmodulin has been combined with acrylamide
and PEG to create stimuli responsive hydrogels. Calmodulin can undergo two conformational
changes from a native state; when bound to Ca2+ it changes into a dumbbell-like conformation
and then into a more constrictive conformation when bound to phenothiazine. In all cases these
hydrogels showed swelling responsive behaviour, in th presence of the external stimuli previously
mentioned [163] and also to trifluoperazine which is a calmodium ligand [164, 165]. Acrylamide-
based glucose sensitive hydrogels have also been synthesised by combining a glucose/galactose
binding protein mutant into the acrylamide network. This protein mutant upon binding to glu-
cose causes a folding eﬀect like a hinge to form a closed state, which was shown to still occur
in response to the presence of glucose when in a protein hybrid hydrogel state [163]. Hydro-
gels that undergo conformational changes in response to enzyme-substrate recognition have also
been explored [13] this system took advantage of enzyme interactions of adenylate kinases with
ATP. Upon binding of an ATP substrate, the adenylate kinase undergoes a large conformational
change closing over the active site. Wild-type adenylate kinases were incorporated into HPMA
polymer networks via cysteine-maleimide conjugation between pendent maleimide groups on the
polymer chain and two cysteine residues present in the wild-type enzyme. The wild-type enzyme
formed cross-links that resulted in the formation of hydrogels and then on the application of an
ATP substrate, a conformation change from the open to closed state of the enzyme was observed
causing a change in hydrogel volume (Figure 1.5C).
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Figure 1.5: Examples of self-assembled protein/peptide-polymer hybrid hydrogels. A) b-sheet
peptide-polymer hybrid hydrogel, schematic adapted from [11], B) Coiled-coil peptide-polymer
hybrid hydrogel reproduced from [12] and C) Protein-polymer hybrid hydrogel adapted from
[13].
1.4 Quantum Dots
Quantum dots (QDs) are semiconducting crystalline nanoparticles ranging in size typically from
2–10 nm in diameter. They have inherently attractive optical properties with a broad absorption
spectrum and a narrow emission profile and are commonly composed of atoms from groups II–VI
or III–V elements in the periodic table, such as PbS, CdSe and InP [166, 167]. Their overall
optical and electronic properties are governed by their size, composition and morphology. They
have been popular alternatives to organic fluorescent dyes, which suﬀer from drawbacks including
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susceptibility to photobleaching and relatively broad absorption and emission bands. In contrast
QDs have robust photoluminescent properties and are much brighter due to low photobleaching
rates. Furthermore, good chemical stability and a narrow tunable emission profile makes them
attractive for applications in biomedical research [168] and as high eﬃciency solar cells/light
emitting devices [169].
As mentioned QDs are typically synthesised from elements situated in groups II–VI or III–V
of the periodic table. They are formed from the rapid injection of organometallic precursors into
a high-boiling and coordinating solvent, resulting in rapid particle nucleation and then using
diﬀerent crystal growth times QDs of a specific size can be generated [170, 171]. However, these
cores tend to have a relatively low quantum yield (less than 10%) so usually a shell of a high
band-gap material such as ZnS is then grown epitaxially around the core to achieve a core-shell
structure. The shell acts to passivate non-radiative recombination sites that can arise from any
surface defects, they also shield the core from photo-oxidation and fundamentally improve the
quantum yield [172].
The small size of QDs results in three-dimensional confinement of electron–hole pairs (ex-
citons) that gives rise to size-dependent photo-physical properties such as absorption, photolu-
minescence and electroluminescence. Excitation of electrons from the valence to the conduction
band occurs when the photon energy exceeds the band gap whereas light emission is the result
of recombination of mobile or trapped charge carriers. The emission wavelength can be tuned
in a broad range (400–2000 nm) by altering either the composition or the diameter of the QD,
as the bandgap increases with decreasing crystalline size [167].
1.4.1 Förster Resonance Energy Transfer
FRET is a non-radiative energy transfer process occurring between an excited donor state (D)
and a proximal acceptor state (A). It occurs through a long range dipole-dipole interaction, in
which there must be suﬃcient overlap between the absorbance of the acceptor and emission
wavelength of the donor, typically the acceptor state will then remit the energy fluorescently.
However, this is not always the case as it can be desirable to not remit fluorescently and quench
the emission of the donor state instead [173]. The rate of energy transfer is highly dependent
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on many factors, namely the extent of spectral overlap, the relative orientation of the transition
dipoles and most importantly the distance between the donor and acceptor. The strong distance
dependence on the rate of energy transfer (kt) of the FRET process is governed by a 6th order
power dependence on the D-A separator (r).
kt(r) =
1
⌧D
✓
R0
r
◆6
(1.1)
Where ⌧D is the donor lifetime in the absence of the acceptor, R0 is known as the Förster
distance and is the distance at which 50% FRET eﬃciency occurs. R0 can be calculated from
the spectral properties of the D and A fluorophores (Equation 1.2).
R0 = 9.78x10
3
⇥
k2n 4QDJ( )
⇤1/6 (1.2)
Where the factor 2 describes the D/A transition dipole orientation ranging from 0 (perpen-
dicular orientation) to 4 (collinear/parallel), however there is no reliable experimental method
to find an absolute value for 2 which leads to some uncertainty in calculations (typically 2/3
is assumed in almost all biological formats) [173]. n is the refractive index of the medium and
QD is the quantum yield of the donor in the absence of the acceptor and J ( ) is the integral of
the overlap between the donor fluorescence and acceptor absorption with respect to wavelength
(Equation 1.3).
J( ) =
ˆ
"A( ).FD( ). 
4d  (1.3)
The overall FRET eﬃciency (QE) is given by:
QE =
kT (r)
⌧ 1D + kT (r)
=
R60
R60 + r
6
(1.4)
Experimentally, the FRET can be determined via either steady state or time resolved mea-
surements of the donor in the presence and absence of the acceptor.
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QE = 1  FDA
FD
(1.5)
QE = 1  ⌧DA
⌧D
(1.6)
F is the donor fluorescence intensity in the absence (FD) and presence (FDA) of the acceptor,
and ⌧ is the fluorescent lifetime of the donor in the absence (⌧D) and presence (⌧DA) of the
acceptor.
FRET usually occurs over nanoscale distances 1-10 nm, which correspond to dimensions of
most biological macromolecules and with intrinsic nanoscale sensitivity to changes in the D/A
separation (proportional to r6) makes FRET very appealing for bioanalysis applications and
is used in a variety of instances [174]. Many FRET configurations and techniques have been
pioneered ranging from quantifying the distance and folding of self-assembling peptides/proteins
[175] to assays to detect the interactions between antigens and antibodies [176]. Particularly
in biosensing materials used for FRET include organic fluorophores, dark quenchers, proteins,
polymers, metal chelates and metal and semiconductor nanocrystals [173]. FRET does have
limitations based on the system components and configurations, for example some fluorophores
are susceptible to photobleaching and interference can exist between acceptor and donor emission
wavelengths. Also, having such a distance dependence results in FRET not being a suitable tool
to measure interactions between large biological macromolecules [174, 168].
1.4.2 Quantum Dot as FRET Biosensors
QDs have many properties which makes them attractive as FRET donors. Firstly their nanoscale
architecture with large surface area to volume ratio allows for them to be decorated with a high
density of surface ligands, which means their inherent optical properties can be easily and eﬃ-
ciently manipulated. For FRET applications in particular, QDs have some notable properties
that render them more suitable than organic dyes such as their narrow size-tunable photolumi-
nescence emission, broad absorption spectra and large Stokes shifts [167]. This has the principal
bonus of allowing for the excitation of mixed QD populations at single wavelength and being far
from their emission wavelengths gives rise for the potential of multiplexed sensing applications.
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Furthermore, the narrow tunable emission profile allows for them to be size-tuned to match a
particular acceptor or multiple acceptor absorption profiles. The ability to eﬃciently improve
the spectral overlap of D to A means a proportional increase in R0, and coupled with the high
quantum yield of QDs intrinsic to the core-shell design permits them to be used in FRET systems
where longer D to A distances are required. Typically with an excitation wavelength situated far
below the corresponding emission wavelength and following careful design, an excitation wave-
length can be selected which corresponds the absorption minimum of the acceptor to prevent
any direct interference with the excitation of the acceptor [177].
1.4.2.1 Quantum Dot-biomolecule Functionalisation Strategies
With QDs being primarily prepared using high temperature solution routes with insoluble salts
they are not normally water soluble and during synthesis are often capped with hydrophobic
ligands such as trioctylphosphine/trioctylphosphine oxide amines and akyl-carboxylic acids [171].
Therefore, to permit their use for biological analysis and the bioconjugation of ligands to their
surface, the hydrophobic ligands must be exchanged for a functional cap that can attach to the
QD surface, providing solubility and stability, and have the capacity to act as a bioconjugation
site. Many capping strategies exist and can be divided into two categories: encapsulation and
ligand exchange [178].
Encapsulation exploits the ability of bifunctional amphiphilic molecules, typically block
copolymers, that consist of distinct hydrophilic and hydrophobic regions. Upon mixing with
QDs the hydrophobic parts of the molecule naturally interact and interdigitate with the native
hydrophobic ligands on the QD surface whilst the hydrophilic segments interact with water
molecules promoting dispersion of the QD in aqueous media. Typical amphiphilic molecules
include either charged groups or PEG chains within the hydrophilic sections to aid the water
compatibility [179, 180, 181, 182, 183]. The main chain is usually designed to have a balance
between these hydrophobic and hydrophilic blocks. In all the cases listed the aﬃnity of the
polymer to the QD surface has involved the removal of the native hydrophobic ligand and the
polymer replacement anchored by ionic interactions. Encapsulation strategies have not only
been limited to amphiphilic polymer molecules other approaches have been employed, namely
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micelle-forming phospholipid derivatives [184, 185], encapsulation into polystyrene microspheres
[186] or growing a silica coating on the QD surface [187].
Ligand exchange involves the substitution of the hydrophobic capping molecules with bifunc-
tional hydrophilic ligands and polymers [178]. The ligands are designed to have an anchoring
group at one end to the quantum dot surface, typically thiol or others (Lewis type interactions)
and a hydrophilic group at the other end (carboxylic, amine and PEG) promoting aﬃnity to
aqueous environments. The ligand exchange process is driven by excess, with a large amount of
ligands required; examples of ligands include mercaptoundecanoic acid [188] dihydrolipoic acid
[189], and other thiol-akyl-carboxylic acids ligands. In some cases, QDs with these surface lig-
ands have limited stability in aqueous buﬀers and are pH-dependent with an improved stability
in basic conditions. To help promote stability in diﬀerent pH conditions, these ligands have been
further functionalised with PEG spacers that help promote stability [190, 191] and contain termi-
nal bio-reactive groups such as biotin, amine and carboxyl groups for conjugation and recognition
of various biomolecules/motifs, via covalent EDC/DCC coupling or avidin-biotin interactions.
These conjugation strategies have had limited success as intermediate aggregates are often de-
veloped following the EDC/DCC condensation and it is hard to deduce how many biomolecules
are bound to the QD surface, with many reactive groups being present and there is the like-
lihood of some non-specific binding. More diverse strategies exist for attaching biomolecules
and recognition sites to QD surfaces such as electrostatic or metal-aﬃnity-driven self-assembly
[192, 14, 17, 16] and direct biotin-avidin chemistry [193, 194]. Metal-aﬃnity driven assembly has
been developed to directly coordinate biomolecules or peptides onto Zn/ZnS-coated QDs via a
polyhistidine (histag), which is specifically included at either the C or N terminal of the peptide
or biomolecule sequence. This strategy is drawn from protein purification processes and benefits
from all the knowledge already gained in this area. Other benefits of this strategy is that the
biomolecule binds directly to the surface, reducing the D to A distance for FRET applications
and also, it has a high dissociation constant (KD ⇡ 0.5   50nM) in neutral and basic pHs
[178]. With this robustness and versatility the strategy has been applied to a variety of peptides
and proteins [192, 14, 17, 16]. Biotin-avidin strategies are another alternative approach; QDs
can simply be purchased with streptavidin conjugated directly to the QD surface and biotiny-
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lated labelled biomolecules can then be directly coupled. The advantages of this strategy is
the high aﬃnity and specificity of biotin-avidin chemistry, with an incredibly high dissociation
constant (KD u 10 15M) [178]. However, this strategy can suﬀer from increased distances be-
tween biomolecule and QD surface preventing its use in certain FRET applications. Each ligand
functionalisation strategy has its own advantages and disadvantages associated with it, and for
FRET sensing applications the selection of strategy is often dominated by the acceptor labelled
biomolecule’s distance, stability and accessibility once attached to the QD surface.
1.4.2.2 Quantum Dot-FRET Enzymatic Assays
QD-FRET has been used over the past few years to investigate a variety of biological processes
and detection of biological targets, such as hybridisation of complementary oligonucleotides
[195, 196, 197, 198], pH and ion sensing of cellular processes [199, 200, 201, 202], as sensors for
enzymatic activity [14, 203, 17, 18, 16, 204, 15, 205, 206] and as platforms for photodynamic
therapy [207, 208, 209]. However, in this section only the use of QD-FRET as sensors for en-
zymatic activity will be discussed. QD-FRET sensors have been used to detect a variety of
diﬀerent enzymes related to many individual biological processes of clinical and pharmaceutical
importance. These sensing assemblies typically consist of QDs conjugated to peptide-substrates,
in which the peptides are designed to have a minimal residue enzymatic recognition sequence.
Multiple dye labelled peptide sequences are then decorated on the QDs surface (via bioconjuga-
tion strategies previously described) bringing the dye acceptors within a close proximity of the
QD, inducing a quenching of the QD photoluminescence. Following the addition of the desired
enzyme, the enzyme will specifically interact with the peptide substrate, for instance a pro-
tease will specifically cleave the peptide substrate and the dye/quencher will displace away from
the nanocrystal, resulting in a progressive reduction of FRET and subsequent recovery in QD
emission. From the rate of cleavage which will be proportional to the protease concentration,
the activity can then be tracked from PL recovery of the QDs. In the first example of sensing
for proteases, QD-FRET assemblies were designed for the cleavage and recognition of capase-1,
thrombin, collagenase and chymatrypsin enzymes (Figure 1.6A) [14]. All peptide substrates
were designed to include N-terminal histag (His6) to self-assemble on the QD surface, a helix
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linker as a spacer providing rigidity and extension from the QD surface, the enzyme recognition
sequence and finally a C-terminal cysteine for simple labeling with Maleimide-functionalised
dye molecules. It was found that this design gave the ability to simply switch between targeted
proteases by altering a small modular unit within the peptide sequences and by correlating the
relative QD photoluminescent decay/FRET eﬃciency with the number of dye-labels per QD
allowed for an estimation of the amount of cleaved substrates at a given enzyme concentration,
highlighting the robustness and sensitivity of QD-FRET biosensors for protease sensing. In a
similar example, using a cap-exchange process, peptide cleavage substrates terminated with a
rhodamine dye were used to functionalise CdSe-ZnS QDs. Peptide cleavage substrates were de-
signed to recognise by either peptidase, trypsin or collagenase enzymes, and with either enzyme
displayed the ability to recover the QD emission. They also demonstrated that in the presence
of an enzyme inhibitor the rate of recovery could be decreased substantially and they even incu-
bated the sensors with cancer cells, demonstrating the presence of extracellular secreted enzymes
[205, 206]. In these cases organic dye molecules were used to quench the QD emission. In another
example gold nanoparticles are used to eﬀectively quench QD PL [15]. Kim et al, synthesised a
series of peptides containing recognition sites for the proteases MMP-7, caspase-3 and thrombin.
The peptides were terminated with a cysteine residue to facilitate the conjugation to maleimide
functionalised 1.4 nm gold nanoparticles and also with biotin to enable association to strepta-
vidin modified QDs. Upon the binding of the peptide–gold conjugate to the QD surface, there
was a significant decrease in QD emission and following cleavage of the peptide by the diﬀerent
proteases, the gold nanoparticles were subsequently released resulting in a dequenching of the
QD emission. The assay was demonstrated both in solution and in a chip format (Figure 1.6B).
By using diﬀerent QDs with diﬀerent emission profiles for each peptide substrate, they were
able to simultaneous detect three types of protease, demonstrating the ability of this system to
multiplex diﬀerent proteases.
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Figure 1.6: Examples of quantum dot-based enzyme assays. A) Protease detection reproduced
from [14], B) Multiplex protease assay reproduced from [15], C) Protein kinase activity assay
reproduced from [16], D) HAT assay reproduced from [17], and E) Multiplexed assay for sensing
of both kinase and protease reproduced from [18].
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QD-FRET is not only limited to the sensing of proteases alone and the principles estab-
lished can be translated for the sensing of other types of enzymatic activity. It has been used
to sense the activity of b-lactamase, a bacterial enzyme which confers resistance to antibiotics.
In this case a peptide substrate was not employed, instead a Cy5 dye labeled core b-lactamase
lactam chemical substrate was utilised and bound to the QD surface via biotin-streptavidin as-
sociation [204]. Addition of the enzyme resulted in hydrolysis of the substrate providing time
dependent changes in FRET eﬃciency and allowed enzyme activity to be monitored over time.
QD-FRET has also been used to sense for kinase activity [16], in this system kinase-mediated
protein phosphorylation was targeted, specifically the activity of two prototypal non-receptor
tyrosine kinases, which play a role in the progression of several cancers. The peptide sequences
H2N- EAIYPFAEEH6-CONH2 and Ac-IYGEFKKKH6-CONH2 were designed to assemble on
the QD surface via histag self-assembly and following the addition of the separate protein ki-
nases, resulted in the phosphorylation of the peptide substrate. The subsequent phosphorylation
was then detected by means of a complementary FRET-acceptor labeled antiphosphotyrosine
antibody, formatting an immunocomplex and allowing for energy transfer between the QD and
FRET-acceptor labeled antibody (Figure 1.6C). Working in the opposite way to the previous
systems discussed, steady-state emission spectra revealed a concomitant decrease and increase,
in QD and dye specific emission respectively as a function of enzyme concentration for both pro-
tein kinases [16] . The design of this system was then adapted to sense for the activity of histone
acetyltransferases (HAT)[17]. Abnormal HAT activity is associated with numerous pathological
conditions such as cancer and HIV infection. The enzyme catalyses the acetylation of lysine
residues. In light of this, the peptide was rationally designed to be based on the H4 N-terminal
histone tail sequence and again to assemble on the QD surface via histag driven assembly. Once
the peptide is incubated with the HAT enzyme in the presence of acetyl coenzyme, the substrate
becomes preferentially acetylated and when added to a QD solution, the peptide was found to
coordinate onto the QD surface via histag self-assembly (Figure 1.6D). Finally, an acceptor-dye-
labeled acetyl lysine specific antibody is introduced and binds to the acetylated peptide on QD
surface, resulting in QD-acceptor energy transfer and an emission profile similar to the protein
kinase in the previous example [16].
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One of the main advantages of using QD for sensing applications is that a single wave-
length can be used for the excitation of mixed QD populations and by careful selection and
separation of their individual emission profiles opens up the possibilities for multiplexed assays
of diﬀerent enzymes. As discussed, a multiplexed assay for diﬀerent proteases was successfully
developed [15] but more interestingly an assay which can simultaneously sense for both kinase
and protease has also been investigated [18]. The targeted enzymes for evaluation were a serine
protease (uro-kinase-type plasminogen activator) and a receptor tyrosine kinase (human epider-
mal growth factor receptor 2). The combination of both these enzymes has been shown to be
clinically relevant, providing significant prognostic information in terms of the metastasis-free
survival of breast cancer patients. The system was designed to contain two separate QD-FRET
systems; the protease sensor is based on a similar system to the AuNP-labeled peptide sub-
strates bound to QDs (525 nm) via biotin-streptavidin coupling [15]. The kinase sensor design
is drawn from previous systems where activity-based signals are developed via the introduction
of dye-labeled antibodies, which recognise the kinase modified peptide substrates self-assembled
onto QD (655 nm) surfaces by histag appended sequences. It was demonstrated that both these
assays could work individually and then simultaneously together, without any cross reactivity
and loss of sensitivity (Figure 1.6E). In these multiplexed systems, either 2 or more QD pop-
ulations are required along with orthogonal coupling strategies for the peptide substrates, or
the QD populations and peptide substrates have to be associated separately and then combined
to enable simultaneous enzyme recognition. In a more recent case, the simultaneous sensing of
multiple proteases has been achieved on the surface of a single population of QDs via a “con-
centric” FRET relay [203]. In this system two separate peptides are bound to the same QD
surface, each peptide is conjugated with separate dyes. The system is designed so that energy
is transferred from QD to first dye, then to the second dye and finally, in a much lesser extent
from QD to the second dye, providing a multitude of signals related to two diﬀerent cleavage
events for trypsin and chymotrypsin proteases. Following protease mediated cleavage of these
substrates, the emission profile was deconvoluted and the enzymatic activity mapped providing
a simpler and more robust approach to the multiplexing of proteases.
Although the QD-FRET systems oﬀer many advantages over molecular dyes in systems which
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utilise energy transfer, they do have certain limitations. The first major limitation is due to their
size, being colloidal in nature they are typically much larger than molecular dyes. So the distance
between QD and acceptor can not be very close and with the minimal separation distance being
slightly more than QD radius. It even becomes greater for red-emitting QDs, which further
limits the range of accessible distances when redder emitting dyes are required [210]. Also,
being inherently non-water soluble can require elaborate surface functionalisation strategies to
bind biological relevant substrates, these strategies can increase the overall conjugate size and
result in a relatively small distance window for the acceptor to be positioned for eﬃcient energy
transfer. Other parameters which limit QDs is shelf life and stability, especially in diﬀerent pH
environments varying dramatically on the surface functionalisation strategy. Finally, QD are
almost entirely limited to being donor fluorophores as opposed to using them as acceptors with
organic dye donors [210]. The limitation arises from QDs having very large extinction coeﬃcients
extending from the UV to the absorption band edge. They also exhibit longer excited-state
lifetimes than organic dyes, meaning they are always excited when used as an acceptor.
1.4.3 Quantum Dot-Polymer Hybrid Biomaterials
Inorganic nanoparticles such as QDs and gold nanoparticles (AuNPs) have received a great
amount of interest due to their unique optical, electrical and chemical properties [211]. Combin-
ing nanoparticles with polymeric networks has huge potential as new hybrid materials, providing
additional functionality and novel properties. This opens up a variety of applications for these
hybrid materials, such as polymeric photovoltaic devices, optics, actuators, microfluidics, drug
delivery and as biosensors [212]. Depending on the type of inorganic particle incorporated, dif-
ferent functionality can be superimposed into the polymer network, for example the inclusion of
super-paramagnetic iron oxide particles can induce magnetic manipulation, bright luminescence
can be achieved with QDs and plasmonic properties with AuNPs. However, to preserve these
properties of the inorganic nanoparticles the hybrid network has to help maintain nanoparticle
stability and oﬀer a degree of robustness to the system, capitalising on the advantages hydro-
gel networks bring in terms of tunable mechanical properties, with a defined morphology, high
porosity and controllable dimensions. The polymer network can also help to improve the bio-
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compatibility of the inorganic particles and act as carrier for targeted delivery applications in
vivo.
QDs have been incorporated into a variety of gel systems including micro-, nano- and bulk
hydrogels. The encapsulation of QDs into such systems has involved two strategies, either by
covalent or non-covalent bonding. Using non-covalent approaches, QDs have been encapsulated
by the diﬀusion of QDs into a preformed hydrogel and then accompanied by trapping through
electrostatic interactions, hydrogen bonding, hydrophobic interactions and host-guest interac-
tions. In contrast, covalent approaches have involved using polymerisable ligands attached to
quantum dot surfaces or ligand exchange procedures. Both strategies have their advantages and
disadvantages associated with them, non-covalent approaches often result in a high concentra-
tion of QD encapsulation but a lack of control over the diﬀusion process often results in loss
of QD stability and aggregation, diminishing the QD PL [213, 214, 215]. Covalent strategies
require the QD to be chemically tailored and requires tedious polymerisation or ligand exchange
processes. In light of this, both a combination of covalent and non-covalent strategies has
been attempted [213]. In general most investigations of QD-hybrid hydrogel networks have been
focused around the chemistry for successful encapsulation and not been particularly application-
driven. In a few examples, QDs have been loaded into poly-N-isopropyl acrylamide (pNIPAM)
networks by both covalent and non-covalent interactions aided by pNIPAMs thermally induced
volumetric phase transitions to form both hydrogels [216] and microgels [217, 218, 219]. These
pNIPAM systems have been used as biochemical monitors, thermo-sensitive devices and as a
sensor [216, 217, 218, 220, 219, 221]. QD hybrid gels have been also been synthesised from PEG
[222], chitosan [223], pullan [224] and alginate [225] networks. Specifically, QD-polymer hybrid
hydrogels for biosensing applications have been relatively unexplored. In one of the few cases
which exist, QDs have been tagged to hydrogel based photonic beads by single strand DNA
crosslinking agents, then formed into a suspension array and upon the specific hybridisation
of target DNA, resulted in hydrogel shrinking, which can then be detected by a corresponding
blue shift in the Bragg diﬀraction peak [226]. This system was found to provide high selectivity
and sensitivity, and also allow for the multiplexing of diﬀerent DNA strands. QDs have also
been physically embedded into Fmoc-diphenylalanine self-assembled hydrogels and used for the
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detection of glucose and toxic phenolic analytes. In this system QDs were simply mixed with
both the self-assembled peptides and the enzymes of interest. Then upon the application of the
analyte and hybridisation by the enzyme, a quenching agent is produced which reduces the PL
of the QDs in the network [220]. In review of these current systems, there is huge scope for the
development of QD-polymer hybrid hydrogels for sensing and biomaterial applications.
1.5 Summary
Hydrogel systems have been applied as fundamental components in a variety of biomaterial and
therapeutic applications. Many hydrogels of diﬀerent compositions have been developed and
investigated made from both synthetic and natural polymers, as well as being formed from the
self-assembly of peptides such as b-sheet, coiled-coils and collagen mimetic sequences. However,
each approach has both advantages and disadvantages associated with them. Synthetic hydro-
gels have mechanical properties that can be easily tailored through its synthetic composition
such as concentration, crosslinking density and molecular architecture but they can suﬀer from
a biocompatibility perspective, being made from non-natural monomers and often need to be
polymerised or crosslinked in situ. The major advantages of self-assembled peptide hydrogels is
self-assembly and gelation can be triggered through external stimuli, such as temperature, pH
and the addition of ions. They also have advantages in biocompatibility, degrading into natural
peptide units and the incorporation of bioactive epitopes. Their principle disadvantage is that
in physiological conditions they suﬀer from quick degradation rates and often fail at low strains,
this can be problematic as cells can exert significant force on their local environment [227].
Self-assembled peptide/protein-polymer hybrid hydrogels are an exciting new class of hydrogel
and have the potential to provide properties far superior to those of the individual components
alone. They have the advantage of being able to superimpose the stimuli responsivity of the
peptide/protein components and the tailorability of the polymer network both in biocompati-
bility and mechanical properties, providing new materials with unique organisations and novel
properties. QDs have superior optical properties to that of organic dyes and QD-FRET have
been successfully used in biosensing for the detection of a variety of enzymes and biomarkers. In
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a few examples QDs have been immobilised into nano-, micro- and bulk hydrogel networks using
either physical embedding or covalent attachment. However, investigations have been limited to
that of the incorporation rather than an overall application for these QD hydrogels. Similarly
to peptide-polymer hybrid hydrogels, huge scope exists to superimpose the advantages QD have
over organic dyes into hydrogel networks and be utilised for novel sensing applications.
60
Chapter 2
Poly (g-glutamic acid)
Characterisation
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2.1 Introduction
g-PGA is an anionic naturally occurring homo-polyamide consisting of repeat glutamic acid
units (Figure 2.1) and is fabricated from various bacteria and archea. It diﬀers structurally from
typical proteins: the repeating glutamate units are formed from amide linkages between ↵-amino
and g-carboxylic acid groups whereas typical peptide units are formed between ↵-amino and ↵-
carboxylic acid groups. The structure can be comprised individually of both d- and l-glutamic
acid or a combination of both depending on its bacterial origin.
Figure 2.1: Chemical structure of g-PGA.
As mentioned g-PGA is synthesised from bacterial origin specifically from a family of genus
called Bacillus. During the synthesis process the polymer is formed as an exocellular capsule
which is then harvested. Several Bacillus species are capable of producing g-PGA. It was first
discovered in a capsule of BacillusAntharis (B. Antharis) [228], however due to its pathogenic
nature this strain is unsuitable for the industrial production of g-PGA. The two most notable
and studied species for the production of g-PGA are (B. Subtilis) and (B. Licheniformis). g-
PGA produced by these organisms are non-pathogenic and is diﬀused freely into the growth
medium during synthesis. In general, the true biological role g-PGA plays is not fully under-
stood, however it is thought that the secreted free g-PGA has numerous roles, including acting
as an extracellular nutrient storage, enhancing biofilm formation, shielding the cells against
phagocytic attacks, and also protecting the cells against high salt concentrations [229, 230, 231].
g-PGA synthesised from B. Subtilis can be further separated into synthesises where the bacterial
organisms require the addition of l-glutamic acid to help stimulate polymer growth. l-glutamic
acid dependent bacteria notably include B. Subtilis IFO 3335 [232] and B. Subtilis F-2-01 [233],
and the l-glutamic acid independent bacteria include B. Subtilis 5E [234] and B. Subtilis TAM-4
[235]. Depending on which type of bacteria used, other factors such as ionic strength, aeration,
62
and medium pH can all aﬀect the composition of g-PGA. Using these nutrient parameters and
culture conditions allows for the control of the yield, molecular weight and ratio of d-/l- glutamic
acid units in the polymer produced [48, 236].
g-PGA and its derivatives have been used in a variety of applications and in a range of indus-
tries, such as in the food industry as a texture enhancer, in cosmetics as a humectant, and water
treatment as a biofloccaunt [229, 230, 231]. More recently there has been a sparked interest in
the biomedical industry, being a naturally occurring polymer as it has many attractive prop-
erties, especially in the field of biomaterials, with many advantages over the currently widely
used hydrolytically degradable polymers. Poly (amino acids) are enzymatically degradable ren-
dering them much more resistant to random chain hydrolysis, preventing rapid deterioration in
scaﬀold strength. g-PGA is degradable by a class of extracellular enzymes called g-glutamyl
hydrolases but is resistant to degradation by proteases which can only cleave the ↵-amino bond
[232, 237, 238, 239, 240].
Due to its polyanionic nature g-PGA is highly water soluble and biocompatible [229, 230,
231]. The chemical structure contains a carboxylic group on the polymer backbone, which
has allowed it to be easily modified to not only incorporate desirable biomolecules but to be
fabricated into composite hybrid materials, hydrogels and scaﬀolds. Previously, it has been
shown that the carboxylic group can be esterified by either ethyl, propyl and benzyl groups to
prevent water solubility [241, 242] and then fabricated into electrospun scaﬀolds, promoting cell
adhesion and supporting osteogenic diﬀerentiation of human mesenchymal stem cells [242]. In
other work, the carboxylic group chains of the polymer have been crosslinked both chemically
and ionically to either itself or another secondary material, to generate many diﬀerent structures
for tissue engineering, drug delivery and biomaterial applications. In a few examples, g-PGA
was grafted with chondroitin sulfate/PCL composite and used as a scaﬀold for cartilage tissue
engineering [243]. It has also been used in a sulfonate form coupled with fibroblast growth
factor-2 as a bioactive substrate [244] and a benzyl esterified form as a carrier vehicle for 5-
fluorouracil [245]. g-PGA has also been combined with chitosan to form composite scaﬀolds for
tissue engineering [246] and for the release of BMP-2 [247]. Being highly water soluble, g-PGA is
ideal for hydrogel platforms. Typical strategies have involved crosslinking and combining it with
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a secondary polymer to form hydrogels. Crosslinkers have included PEG-methacrylate [248, 47],
peroxides and diamino compounds [249, 250] and it has been combined with poly(acrylamide)
[251], chitosan [252] and polyvinyl alcohol [253].
In light of the unpredictable nature of g-PGA synthesis from bacterial origin with the prop-
erties and composition being heavily aﬀected by nutrient parameters and culture conditions,
it was sought to quantitatively characterise the g-PGA synthesised from B. Subtilis which we
received. Nuclear magnetic resonance spectroscopy (NMR) and fourier transform infrared spec-
troscopy (FT-IR) were used to verify the chemical structure and size exclusion chromatography
(SEC) was utilised to quantify the molecular weight and polydispersity of the polymer. Fur-
thermore, g-PGA synthesised from B. Subtilis is known to produce a polymer consisting of a
ratio of both d-/l- glutamic acid units, and can adopt ordered structures stabilised by intra-
and intermolecular hydrogen bonds between amide groups. The ratio and distribution of the d-
and l- units are likely to have an eﬀect on the ordering and conformation of the structure giving
rise to potentially cooperative folding, which will have an eﬀect on the polymers’ properties. To
probe the presence of ordered conformations, circular dichroism (CD) spectroscopy was used on
native g-PGA at diﬀerent pH.
2.2 Materials and Methods
2.2.1 Poly ( -glutamic acid) Preparation
g-PGA was purchased in its sodium salt form (g-PGA-Na+) produced by B. Subtilis; Natto
Science\varpi Ltd, Japan). g-PGA-Na+ was first dissolved in 200 mL of deionised water (DI
H2O). The solution was acidified with 6M HCl to a pH of 1.5 and subsequently lyophilized for
48 hours. Next, the lyophilized g-PGA was suspended in N,N-dimethyl sulfoxide (DMSO) at 0.1
wt% while stirring for 24 h at 80 °C. The mixture was then cooled down to room temperature.
Once at room temperature an excess of acetic anhydride was added drop wise to the mixture
and stirred for 30 minutes to cap the end terminal amines of the polymer chains. To react
any excess acetic anhydride, a further addition of water was added in a two-fold molar excess
to the acetic anhydride and stirred for 30 minutes. The mixture was then purified by dialysis
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(using a Spectrum Labs regenerated cellulose membrane with molecular weight cut oﬀ, MWCO
50,000 Da) and the resultant dialysed polymer solution, was lyophilized yielding the final native
g-PGA-H material.
2.2.2 Poly ( -glutamic acid) Characterisation
2.2.2.1 Nuclear Magnetic Resonance Spectroscopy
NMR spectra were recorded on a Bruker Biospin GmbH AV500 (operating at 500 MHz for 1H;
125.76 MHz for 13C, using DMSO-d6 as a deuterated solvent. 1H-NMR spectra were referenced
to the residual protons in the deuterated solvent. Data is described as follows: chemical shifts
are in ppm in the scale; multiplicity (s: singlet, d: doublet, t: triplet, q: quartet, m: multiplet,
bs: broad signal); integration; assignment. 13C-NMR spectra were referenced to the solvent
chemical shift.
1H-NMR (DMSO-d6) d ppm: 1.73 (m, 1H, CH); 1.93 (m, 1H, CH); 2.19 (t, 2H, CH2CO);
4.13 (m, 1H, CHNH); 8.21 (d, 1H, NH).
13C-NMR : 27.02 (CH2); 31.59 (CH2CO); 51.59 (CHNH); 171.66 (CONH); 173.43 (COOH).
2.2.2.2 Fourier Transform Infrared Spectroscopy
To further identify the chemical structure of g-PGA-H, FT-IR was carried out on the lyophilized
g-PGA-H using a Perkin-Elmer Spectrum 100 FT-IR Spectrometer (650-4000 cm-1) at a reso-
lution of 1 cm-1 and averaged from 52 consecutive scans.
2.2.2.3 Size Exclusion Chromatography
To determine the molecular weight distribution of g-PGA-H, SEC was performed, in which g-
PGA-H was dissolved at concentration of 2 mg/mL in eluent (0.2 M NaNO3, 0.01 M NaH2PO4,
pH7) and left overnight to dissolve. The solution was then filtered with a 0.45 µm membrane and
aliquoted into 10 mL samples. SEC was carried out using a Viscotek GMPWXL (30 cm, 10 µm)
column, with a 1 mL/min flow rate at 30ºC, with triple detection (refractive index, diﬀerential
pressure and light scattering) and a narrow molecular weight (Mw) PMMA standard. Two
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g-PGA-H samples were run and performed courtesy of Smithers Rapra.
2.2.2.4 Acid-base Titrations
Acid-base titrations were used to give indication of pKa of g-PGA-H and to verify the monoprotic
acidic nature of the polymer. For titrations, 50 mg of g-PGA-H was dissolved in 50 mL 0.02 M
NaOH solution to obtain a starting pH t 12. Then 50 µL additions of 1.0 M HCl were added
to the solution and pH recorded following each addition until pH t 2 was achieved. The pH
was then plotted against the corresponding volume of HCl added, to generate a titration curve
and the pKa of the polymer from equivalence points on this curve. To determine the pKa, the
following equilibrium equation can be employed (Equation 2.1)
pH = pKa + log10
✓
[A ]
[HA]
◆
(2.1)
Where [HA] is the molar concentration of the undissociated acid and [A ] is the molar
concentration of this acid’s conjugate base. At the equivalence point of the acid-base titration,
the concentrations of the two species are equal ([HA] = [A ]) so the equation becomes (Equation
2.2).
pH = pKa (2.2)
2.2.2.5 Secondary Structure Characterisation
CD is a technique that can be used to determine secondary structural characteristics of proteins,
poly peptides, peptides and more recently biopolymers [254, 255]. A CD signal is generated by
passing left- and right-handed circularly polarised light of equal amplitude through a sample
at a range of wavelengths, specifically in the far UV (175 - 250 nm) for proteins, peptides
and biopolymers, and then subsequently determining the diﬀerence in absorption of both light
components, Equation 2.3.
 A = AL  AR (2.3)
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This diﬀerence in absorption can easily then be manipulated into the extinction coeﬃcients
(Equation 2.4) and in turn can be converted into molar ellipticity (✓) (Equation 2.5), which is
the common unit for reporting the intensity of CD signals.
 A =  ✏cl (2.4)
✓ = 3298 ✏ (2.5)
In order for a CD signal to be generated, the system must possess either local or global
chirality; a system which is achiral will produce no CD signal. After passage of the incoming
circularly polarised light through the sample, if the left and right-handed components are not
absorbed or are absorbed to equal extents the resultant recombination of L and R would be
polarised in the original plane generating no signal. However, if L and R are absorbed to diﬀerent
extents, the resulting recombination would possess elliptical polarisation and a diﬀerence in signal
is generated, representing a chiral molecule. Since the signals are generated from a diﬀerence
measurement, it is common for the bands to be either positive or negative [254, 255].
CD measurements were carried out on a JASCO J-810 CD spectrometer. g-PGA-H solutions
at diﬀerent pHs were made by first dissolving g-PGA-H at 5 mM in DI H2O and then altering the
pH with either 1 M NH4OH or HCL solution, and then finally diluting to 1 mM with additional
pH adjusted DI H2O. All scans were performed at 25°C from 195-250 nm at 0.1 nm intervals
with averaging time of 3 seconds and using a 0.1 cm path length quartz cell cuvette. Spectra
were averaged across 3 scans and corrected via a background subtraction of the baseline solvent.
The mean residue ellipticity ([j], deg cm2 dmol-1) was calculated treating each repeating unit
of the polymer as an individual residue.
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2.3 Results and Discussion
2.3.1 Poly (g-glutamic acid) Characterisation
2.3.1.1 Nuclear Magnetic Resonance Spectroscopy
The chemical structure of the preparedg-PGA-H was initially investigated and verified by both
1H-NMR (Figure 2.2 A) and 13C-NMR (Figure 2.2 B).
Figure 2.2: A) 1H-NMR and B) 13C-NMR spectra of g-PGA-H (DMSO-d6).
From the peak integration it was possible to assign the 1H spectra. Firstly, the proton of
the amide group on the polymer backbone (labelled x) is present at 8.21 and the proton of
↵-CH carbon can be seen at 4.13, both with an equal integration of 1. The two protons of the
 -CH2 carbon (labelled d) can be seen at 2.19 and integrates to be 2, twice that of the single
68
hydrogen peaks. Finally, the  -CH2 is represented interestingly by two distinct peaks at 1.93
and 1.73, both integrating to 1, this is thought to be because of a restricted spin of one of the
protons caused by an intramolecular association between the proton and the carbonyl on the
polymer backbone, giving rise to the replicating of two proton environments. Using 13C-NMR,
more of the chemical signature of g-PGA-H can be determined, the carbon of carbonyl group
(labelled y) on the polymer backbone is visible and so too that of carbon of the carboxylic
group side chain (labelled z). From these two complementary spectra and peak assignment, the
chemical structure of the prepared g-PGA-H was verified and has the expected g-polypeptide
form, confirming its purity .
2.3.1.2 Fourier Transform Infrared Spectroscopy
The chemical structure of g-PGA-H was further investigated with FT-IR, the characteristic
bands were successfully identified [256] and can be viewed in Figure 2.3.
Figure 2.3: Fourier transform infrared spectra of g-PGA-H.
As seen in Figure 2.3, the peptide amide bond inherent to the homo-polyamide backbone of
g-PGA-H can be identified by the strong amide I and II bands visible bands at 1640 cm-1and
1573 cm-1. The characteristic peaks for the -CONH- group displayed a weak and shifted band
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at 3276 cm-1 likely due to the solid state of the polymers, and finally the alkyl CH2 group of the
backbone was present at 2921 cm-1. The characteristic bands of interest for the carboxylic acid
side group of g-PGA-H, include the R-COOH, R-OH and COO- bands. The -OH band for both a
carboxylic acid and hydrogen bonded -OH tend to be very broad spanning 2500 - 3200 cm-1and
is present in this spectra. The -COOH band typically around 3550cm-1 is shadowed/merged
mostly by the broad -OH band, however a small shoulder can be seen at 3552 cm-1 which could
be representative of the -COOH group. With such a large density of -COOH present in the
polymer, the -OH and -COOH bands should have a much greater intensity than is present, the
suppression in these bands could be attributed to the low pKa (⇡ 4.25) of g-PGA-H resulting in
some deprotonation of -COOH groups or also could be caused by the solid nature of the sample.
Finally, the carbonyl group COO- can be recognised by the sharp strong peak at 1720 cm-1and,
furthermore, a strong visible peak is present at 1213 cm-1which is thought be representative
of the C-O bending band of the -COOH group but is diﬃcult to conclude being in the lower
wavenumber region of the spectra.
2.3.1.3 Size Exclusion Chromatography
To determine the molecular weight distribution of g-PGA-H SEC was carried out. From the
molecular weight distribution, the final values are summarised in Table 2.1.
g-PGA-H Sample Molecular Weight (Mw) Molecular Number (Mn) Polydispersity (Ð)
1 282,000 Da 117,000 Da 2.4
2 283,000 Da 118,000 Da 2.4
Table 2.1: Molecular weight distribution data for g-PGA-H.
From the data, the g-PGA-H samples contain a clear polymeric component of a high molecu-
lar weight and relatively good polydispersity considering the synthesis is from a bacterial origin.
2.3.1.4 Acid-base Titrations
To determine the monoprotic nature and pKa of g-PGA-H, an acid-base titration was performed
and the corresponding titration curve can be viewed in Figure 2.4.
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Figure 2.4: Acid-base titration for g-PGA-H.
From the titration curve it is apparent that there are two equivalence points. The first (e1)
corresponds to the neutralisation of the excess OH-from initial NaOH addition, which was added
to obtain a basic pH starting point. The second equivalence point (e2) is therefore representative
of the protonation of g-PGA-H. The high density of carboxylic acid groups present in g-PGA-
H requires a large concentration of acid to be added to deionise all of these groups. This
results in the region of the curve being quite shallow resembling buﬀer-like behaviour, making
the corresponding e2 diﬃcult to determine. However, using this equivalence point and the
relationship established in Equations 2.1 and 2.2, the pKa of g-PGA-H can be estimated to be
t 4.25, which agrees well with previous literature examples [257].
2.3.1.5 Secondary Structure Characterisation
g-PGA-H is a g-polypeptide where ordered conformations of such structures are diﬃcult to
predict and recognise, unlike ↵-polypeptides whose secondary structures such as ↵-helix and
 -sheet are extensively studied. In previous work, g-oligopeptides have been found to be able
to adopt stable helical conformations [258, 259, 260, 261, 262, 263] and can undergo helix-coil
transitions [264] despite the presence of additional -CH2- groups in the backbone that could
increase the disorder or hamper conformational order in the chain. As previously mentioned
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g-PGA-H is a bacterial produced poly (g-peptide) which has been shown to adopt these ordered
structures, with the structure stabilised by intra- and intermolecular hydrogen bonds between
amide groups. Depending on its bacterial origin, g-PGA-H can either be predominantly formed
from either d- or l- glutamic acid units, or a mixture of both. g-PGA-H produced by B. Anthracis
and B. Lichenformis, is known to be formed predominantly from the d-glutamic acid isomer,
whereas both d- and l- sub units are commonly found in g-PGA-H produced by B. Subtilis. The
d- and l- units are thought to form stereo-blocks, that are alternatively linked and unevenly
distributed in the polymer chain [265].
Helical structures have been proposed for g-(d)PGA-H produced by B. Anthracis and syn-
thetically produced g-(l)PGA-H using CD, and complemented with optical rotatory dispersion
studies [253, 266]. The CD spectra in these studies shows that both g-(d)PGA-H and g-(l)PGA-
H have a pH dependent CD signature and are mirror images at the same pH, with identical bands
of the same intensity but with opposite signs respectively. In g-(d)PGA-H unionised form (pH
2), the spectra display a negative maximum at 206 nm and a positive band just below 195 nm,
and in contrast g-(l)PGA-H showed a maximum at 206 nm and negative band just below 195
nm. In their ionised form at neutral and alkaline pH, the CD signatures change with a positive
shift and reduction in the negative/positive maximum accompanied by a shift in the crossover
and positive/negative band previously at 195 nm for the g-(d)PGA-H/g-(l)PGA-H respectively.
Repeating this experiment with the g-PGA-H which we received, formed from the B. Subtilis
strain, the CD spectra at diﬀerent pH can be viewed in Figure 2.5.
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Figure 2.5: CD spectra of g-PGA-H at diﬀerent pH.
Interestingly, the CD spectra of this strain has similar spectral features and resembles that
of the g-(d)PGA-H produced by B. Anthracis, adopting an ordered conformation predominantly
formed from d-glutamic stretches despite being thought to contain both an abundance of d-
and l-glutamic sub units. More recently, using molecular dynamics and quantum mechanical
calculations [267, 268, 269, 270], the conformation of g-(d)PGA-H has been probed and thought
to adopt a left-handed helix with hydrogen bonds set between CO of the amide group i and the
NH of the amide group i + 3 in its ionised form. At alkaline pHs where g-(d)PGA-H is in its
unionised form, the breaking of the inter-carboxyl hydrogen bonds results in a helix-random coil
transition where the deprotonation compromises the stability of the helical formation. This is
supported by our data, by the change in CD spectra displayed at a neutral and basic pH. This
emphasises that the g-PGA-H received resembles the structure of g-(d)PGA-H and is thought to
have a cooperative left hand helical formation in its ionised form, also exhibiting a helix-random
switch when deprotonated.
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2.4 Conclusions and Future Work
This chapter has described the preparation and characterisation of the g-PGA-H material re-
ceived. Using NMR and FT-IR the chemical structure was probed and found to resemble the
expected native structure. Using SEC the molecular weight distribution was estimated; it was
found that the g-PGA-H had an inherently high molecular weight and narrow polydispersity
considering the nature of the synthesis from bacterial and not synthetic origin. Following acid
base-titrations the monoprotic nature of the g-PGA-H was confirmed enhancing the verification
of the chemical structure, the pKa was also calculated and found to be ⇡ 4.25. With the polymer
being synthesised from the B. Subtilis bacterial strain, which is known to produce a polymer
consisting of a ratio of both d-/l- glutamic acid units and from previous investigations, has been
found to adopt ordered structures. These ordered structures have been in turn shown to be
aﬀected by the ratio and distribution of the d- and l- units and can give rise to potentially coop-
erative folding. With this in mind, the secondary structure of g-PGA-H was probed using CD
and thought to be more representative of g-(d)PGA-H secondary structure and following molec-
ular dynamic studies has be shown to adopt a left-handed helix and undergo a helix-random coil
transition when deprotonated.
To further enhance and verify the understanding of the material received, especially regarding
the secondary structure, a CD thermal unfolding study could be completed on g-PGA-H in its
un-ionised form to see if there is a thermal unfolding of the polypeptide chain, this would
further indicate the presence of cooperative folding and the stability of the conformation under
denaturing conditions. To verify the opposite CD signatures of the g-(d)PGA-H and g-(l)PGA-H
stretches [253, 266], oligopeptide sequences of 24 repeat residues could be synthesised consisting
entirely of either the d- or l- sub units in an attempt to mimic the individual d- and l- polypeptide
stretches. The CD signatures of each of the diﬀerent oligopeptides should be opposite, with the
g-PGA-H signature resembling that of the d-oligomer and the g-(d)PGA-H spectra. Another
interesting experiment would be to try to replicate the structure of g-PGA-H made from the
B. subtilis strain, again using representative oligopeptide sequences, diﬀerent combinations of
the individual d- and l- both subunits could be synthesised and then investigated using similar
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CD techniques. The sequences would need to be systematically designed, as it is likely that
a sequence of equal and alternatively stationed d- and l- subunits would provide a system of
no global chirality and hence no CD signal. However, using rationally designed oligopeptide
sequences of diﬀerent combinations and orders, accompanied by molecular dynamic simulations
would make it possible to recognise at which point the global chirality change causes cooperative
folding and the ordering of g-PGA-H. Not only would this be useful information to understand
the diﬀerent conformations of g-PGA-H which arise from diﬀerent synthesis methods and how
this impacts on the polymeric properties, but it may help to predict and recognise ordered
conformations of diﬀerent g-polypeptides, which are notably hard to predict.
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Chapter 3
Self-Assembled b-Sheet Peptide Hybrid
Poly (g-glutamic acid) Hydrogels
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3.1 Introduction
Tissue engineering strategies typically utilise biomimetic scaﬀold materials to provide mechan-
ical support for cells and can be functionalised with bioactive moieties to help elicit a desired
cellular response [21]. These scaﬀolds are often made from soft materials, such as nanofibrous
polymer scaﬀolds and polymer or peptide hydrogels, which are attributed with diﬀerent sets of
properties. Nanofibrous polymer scaﬀolds are fabricated from well characterised and established
FDA approved polymeric materials. However, they suﬀer from the diﬃculty to graft and in-
corporate biomolecules and also, they can only be designed over a limited range of stiﬀnesses
which limits their use for specific cell types and applications. Covalently crosslinked polymer
hydrogels generally have superior mechanical properties, that can be tailored through concen-
tration, crosslinking density and molecular architecture [271], but are often made of non-natural
monomers and need to be polymerised or crosslinked in situ. Self-assembled peptide hydro-
gels can be used as injectable systems, with gelation occurring through the introduction of ions
present in physiological solutions or added separately, and are able to recover their mechanical
properties after large strains since non-covalent bonds can reform after rupture [123]. They also
have advantages in terms of biocompatibility, degradation into natural peptide units and easy
incorporation of bioactive epitopes [116, 103]. However, in physiological conditions they suﬀer
from quick degradation rates and often fail at low strains, which can be problematic as cells can
exert significant force on their local environment [227]. In light of all these properties assoicated
with typical scaﬀold materials, it was sought to capitalise on the inherent disadvantages and
design a platform system which could compensate for these disadvantages and be used in a
variety of tissue engineering applications.
Polymers conjugated with peptides are widely used in tissue engineering applications [272,
273]. In most cases the peptide sequences are included to help bind to cells and promote a
specific biological response, such as cell adhesion or receptor signaling. However, little research
has been focused on utilising peptides sequences and their ability to self-assemble through non-
covalent interactions to create hydrogels. The theory being that, mechanically, the hydrogels
will be attributed with the strain-resistance and tailorability of a polymer hydrogel, but can
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recover and assemble like a peptide hydrogel providing a platform with the advantages of both
polymer and peptide hydrogels. Non-covalent interactions have been successfully used to provide
added functionality and responsiveness to polymer networks especially in “self-healing” [274,
275, 276]. Most living tissues are inherently anisotropic, as they have to combat an extreme
range of mechanical environments present in the body, adding complexity when engineering a
scaﬀold for such tissues. One way to approach this engineering problem would be to develop a
scaﬀold that can “self-heal”, providing a recovery in mechanical properties after the application
of large strains. It was hypothesised that the use of non-covalent b-sheet peptide crosslinks
would provide the necessary driving force to reassemble polymer chains following deformation
induced by large strains. In previous work, peptides designed to guide the organisation of
polymer networks through peptide self-assembly have included coiled-coil [162, 277] and b-sheets
[278, 279]. Specifically, the self-assembly of b-sheets motifs have been utilised in block copolymers
[154, 155, 151] as nanofiber-forming grafts to synthetic polymer networks [280, 157] and more
recently as cross-links in hydrogels [156, 158].
Another important design feature for tissue engineering scaﬀolds is bioactivity and the abil-
ity to easily encorporate biological epitotes that can induce a desired cellular response. As
previously mentioned, natural polymeric materials have many advantages over synthetic hy-
drolytically degradable polymers in terms of bioactivity, degrading into naturally occurring
units and also having the ability to incorporate receptor binding ligands to cells, susceptibility
to cell-triggered proteolytic degradation and natural remodelling. Taking this into account we
designed a biodegradable polymer-peptide hybrid hydrogel, that consists of a g-PGA polymer
network which is physically cross-linked via conjugated self-assembled b-sheet peptide sequences.
In terms of bioactivity this would yield a system made entirely from peptide bonds and would be
comprised mostly from a naturally occurring polymer which is enzymatically degradable, highly
biocompatible and water soluble [281, 236]. In its high molecular weight form g-PGA requires
at most 15% of b-sheet motifs leaving a large majority of carboxylic groups that can be easily
modified with biomolecules such as additional peptide sequences to design for specific applica-
tions. In previous work, we have shown that g-PGA-H and its derivatives can be used to create
tissue engineering scaﬀolds that promote cell adhesion and support osteogenic diﬀerentiation of
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human mesenchymal stem cells [242].
In this chapter, the synthesis and characterisation of a g-PGA-b-sheet hybrid hydrogel system
is discussed. We investigate how small alterations to the b-sheet peptide sequence and changes in
b-sheet peptide graft density, allow for the tailoring of the hydrogel’s stiﬀness. The ability to tune
mechanical properties of tissue-engineering scaﬀolds is an important design feature as cellular
behavior has been found to be heavily influenced by the mechanical properties of the surrounding
environment [124]. The hydrogel’s response to cyclic loading environments and their recovery
following the exposure to high strain is also investigated. CD, FT-IR and Thioflavin (ThT)
binding techniques were utilised to probe the secondary structure in the polymer-peptide hybrid
hydrogels. Following b-sheet conjugation, a large majority of carboxylic groups are available for
further peptide functionalisation, so we additionally functionalised 1% of the carboxylic acids
on the polymer backbone with the cell adhesion peptide Arg-Gly-Asp (RGD) to demonstrate
that these hydrogels can be modified to enhance bioactivity.
3.2 Materials and Methods
3.2.1 b-Sheet Peptide Synthesis
3.2.1.1 b-Sheet Peptide Synthesis
Peptides can be easily synthesised using well-stablished and practiced solid phase methods [282].
Briefly, in this method, amino acid monomers are conjugated in series, growing a peptide chain
which is in turn tethered by a cleavable bond to a polymeric based solid resin. The peptide chain
is grown by the repeat formation of amide bonds between amine and carboxylic groups present
on the amino acid monomers. In each conjugation step, the reactive N-terminal amino group
of the peptide sequence is reacted in excess with an ester derivative of the subsequent amino
acid in the growing peptide sequence. To prevent any self-polymerisation or cross reaction, the
incoming amino acid’s N-terminus is protected with a protecting group which is easily removed.
After amide bond formation, the N-terminus of the coupled amino acid is deprotected and
washed copiously with solvent to remove any by-products and unreacted amino acid, and then
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the amino acid coupling process is repeated until the peptide chain reaches its desired sequence.
During the amino acid conjugation process any potential side reactions with previously coupled
amino acid side chains are prevented by the protection of the amino acid side groups, which
are easily removed at the end of the synthesis. Depending on the desired peptide sequence and
application, amino acids side chains can be incorporated with specific protecting groups which
have a variety of deprotection cocktails that can allow for the incorporation of other molecules
such as dyes whilst the peptide chain remains tethered to the resin. After completion of the
peptide sequence, the peptide is cleaved and subsequently removed from the resin along with
the side chain protecting groups yielding the final peptide chain. This method can be readily
used to make relatively pure short peptide sequences < 25 amino acids, however with longer and
more complicated peptide sequences, this method can pose synthetic problems and recombinant
bacterial expression systems can be a more suitable method for producing these types of peptide
sequences.
Three diﬀerent b-sheet peptide sequences were synthesised with either six Ile (I6b) or Gln
(Q6) residues in the central b-sheet region, and to investigate how length of the b-sheet eﬀects
the properties of the hybrid hydrogel a peptide with four Ile (I4b) residues was also synthesised.
These three peptide sequences were synthesised using a manual solid-phase method, in which
all resins, Fmoc-protected amino acids and solvents were purchased from AGTC Bioproducts
UK. Briefly, all synthesis was carried out of a 0.5 mmol scale on MBHA rink amide resin.
Initially, the resin was allowed to swell in dichloromethane (DCM) for 30 minutes. From each
amino acid coupling the N-terminal Fmoc protecting group was removed by incubating the
resin with a solution of 20% piperdine in N,N-dimethyl formamide (DMF) whilst agitating for
10 minutes, this was repeated twice. The resin was then washed with copious amounts of
DCM and DMF. The oncoming amino acids were activated by a 4 molar equivalents addition
of O-Bensotriasole-N, N, N’, N’-trimethyl-uronium-hexafluoro-phosphate (HBTU) and 6 molar
equivalents of diisopropylethylamine, and then left to dissolve in 30 mL of N-methylpyrrolidone
for a few minutes before being added to the deprotected resin. The coupling reaction was
allowed to proceed for two hours whilst being agitated. Following the reaction the resin was
washed again with DCM and DMF, and a ninhydrin test performed to check for the presence of
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any unreactive amines. If the test proved to be postive the coupling reaction was repeated. All
peptides were cleaved by shaking the resin in a peptide cleavage solution of 95% trifluoroacetic
acid (TFA), 2.5% triisopropyl silane and 2.5% DI H2O for 3 hours. The cleavage solution was
then drained into a round bottom flask and the resin rinsed with DCM, All liquid was removed
using rotory evaporation, precipitated and washed with cold diethyl ether (DEE), then left to
dry under vacuum.
3.2.1.2 b-Sheet Peptide Purification
I4b peptide was dissolved at 5mg/ml in a solution of 95% DI H2O, 4.9% acetonitrile, 0.1%
NH4OH and doped with 20 mM ammonium formate, the I6b and Q6 peptide was completely
insoluble in water preventing any further purification process. The solution was passed through
a 0.2 micrometer filter and injected into a semi-prep reverse scale HPLC running on a mobile
phase gradient of 95% DI H2O and 5% acetonitrile to 95% acetonitrile. 0.1% ammonia was added
to both mobile phases. I4b peptide was purified by high-performance liquid chromatography
(HPLC) using a Phenomenex C18 Gemini NX column with a 5 micron pore size, a 110 Å
particle size and with the dimensions 150 x 30 mm under basic conditions and doped with 20
mM ammonium formate to help aid solubility and separation. The peptide identities of the
I4b were verified via matrix-assisted laser desorption/ionisation mass spectrometry (MALDI)
courtesy of the Chemistry Department, Imperial College London, using a MALDI micro MX
(Micromass, Manchester, UK). The I6b and Q6 peptide were insoluble in water, which prevented
a similar purification process, so the resultant peptides were first dialysed (using a Spectrum
Labs regenerated cellulose membrane with molecular weight cut oﬀ, MWCO 1,000 Da) against
Di H2O for 24 hours, then lyophilised and purity confirmed by electronspray ionisation mass
spectrometry (ESI) and liquid chromatography–mass spectrometry (LC-MS) respectively.
3.2.1.3 b-Sheet Peptide Secondary Structure Characterisation
CD measurements were carried out on a JASCO J-810 CD spectrometer. Peptide solutions at
diﬀerent pHs were made by first dissolving g-PGA-H at 2 mM in DI H2O and then pH adjusted
with either 1 M ammonia or 1 M hydrochloric acid (HCl), and finally diluted to 1 mM with
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additional pH adjusted DI H2O. All scans were performed at 25°C from 195-250 nm at 0.1 nm
intervals with averaging time of 3 seconds and using a 0.1 cm path length quartz cell cuvette.
Spectra were averaged across 3 scans and corrected via a background subtraction of the baseline
solvent. The mean residue ellipticity ([j], deg cm2 dmol-1) was calculated for the peptides of
diﬀerent sequence lengths.
3.2.2 Synthesis of Self-Assembled b-Sheet Peptide Hybrid Poly (g-glutamic
acid) Hydrogels
g-PGA-H was prepared as previously described. The lyophilised product was dissolved at a
known concentration (5 wt%) in DMSO at 80 °C whilst stirring until a completely clear solution
was obtained. The solution is then cooled to room temperature and the carboxyl groups of
the g-PGA-H solution activated in the presence of diisopropylcarbodiimide (DIC) at a molar
equivalence of 20% and left to stir for 24 hours. The complete conversion of DIC functionalised g-
PGA-H after 24 hours was verified with the removal of an aliquot of the solution, which was then
precipitated and washed in DEE and dissolved in deuterated H2O. The DIC functionalisation
was subsequently confirmed by 1H-NMR.
Next, the b-sheet peptide sequences were dissolved in trifluoroacetic acid (TFA) to disaggre-
gate the peptide, dried under vacuum and then re-dissolved in DMSO at 5 wt%. Finally the
b-sheet peptides in DMSO were added to the stirred DIC functionalised g-PGA-H solution at the
desired molar equivalences and left to conjugate for 24 hours. After coupling DMSO solutions
were dialysed (using a Spectrum Labs regenerated cellulose membrane with a MWCO 8,000 Da)
against DI H2O for 3 days, with the DI H2O changed twice daily. The hybrid hydrogels formed
gels in the dialysis bags in the first few hours of dialysis. The amount of b-sheet peptides present
in the diﬀerent hybrid hydrogels was then determined by 1H-NMR, in which the b-sheet peptide
functionalisation was estimated to be around 15% (g-PGA-15% I6b and g-PGA-15% I4b) or
7.5% (g-PGA-7.5% I6b).
3.2.2.1 Nuclear Magnetic Resonance Spectroscopy
1H-NMR spectra were recorded on a Bruker Biospin GmbH AV400 operating at 400 MHs using
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DMSO-d6 as a deuterated solvent. Following dialysis, 50 µl gel samples were lyophilised, first
dissolved in TFA, dried under vacuum and then re-dissolved in DMSO-d6 at 0.5 wt%. 1H-NMR
spectra were referenced to the residual protons in the deuterated solvent (2.5 for DMSO-d6).
3.2.3 Characterisation of Self-Assembled b-Sheet Peptide Hybrid Poly (g-
glutamic acid) Hydrogels
3.2.3.1 Rheological Studies
All rheological studies were preformed on a TA-AR200 rheometer using 40 µL gel samples, a
8mm parallel plate geometry with a 0.5 mm gap distance at 25 °C. Frequency sweeps were
performed at 1% strain fixed with a varying oscillation frequency of 0.1 - 200 rad s-1. Strain
sweeps maintained a fixed oscillation frequency of 6.283 rad s-1 and variable applied strain of
(0.01 - 200%). For the recovery experiments three identical strain sweeps were performed in series
with a 30 min rest time in between each strain sweep. For the cyclic strain measurements, the
hydrogels were subjected to an immediate series of strain sweeps with incrementally increasing
strains from (0.01% - 1, 2, 5, 10, 15, 20, 30, 50 and 100%) at a fixed oscillation frequency of
6.283 rad s-1.
3.2.3.2 Circular Dichroism
CD measurements were carried out on a JASCO J-810 CD spectrometer. All the hydrogels were
additionally hydrated with DI H2O to normalise the polymer concentrations across all gels and
g-PGA-H solutions. All scans were performed at 25°C from 195-250 nm at 0.1 nm intervals
with averaging time of 3 seconds and using a 0.1 mm path length quartz plate cuvette. Spectra
were averaged across 3 scans and corrected via a background subtraction. The mean residue
ellipticity ([j], deg cm2 dmol-1) was calculated with an average molecular weight of one residue
assumed for all the hybrid hydrogels.
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3.2.3.3 Thioflavin T Binding Studies
Fluorescence spectroscopy was used to determine the formation of b-sheet structures in the
hybrid hydrogels. The hydrogels were further hydrated with either DI H2O or an addition of
6M guanidium chloride (GndCl), normalising to the polymer concentration across the gels. As
a control, g-PGA-H was also dissolved in both DI H2O and 6 M GndCl at the same polymer
concentration of the hydrogels. ThT was dissolved at 1 mg/ml and filtered through a 0.2 m
syringe filter to make a 0.1 wt% stock solution. The ThT stock solution was then diluted 1:50
in DI H2O, g-PGA-H or the hybrid hydrogels and incubated for 2 hours. Spectroscopic studies
were completed by exciting at 440 nm and recording the emission spectra from 450 nm to 700 nm
at 2 nm intervals, using a SpectraMax M5 microplate reader (Molecular Devices, Wokingham,
UK).
3.2.3.4 Fourier Transform Infrared Spectroscopy
To further identify the formation of b-sheet structures in the hybrid hydrogels, FT-IR was
carried out using a Perkin-Elmer Spectrum 100 FT-IR Spectrometer in the amide I region
(1550-1700 cm-1) at a resolution of 1 cm-1 and averaged from 52 consecutive scans. The hybrid
hydrogels were lyophilised, and the resultant dried material used for analysis. All the spectra
were normalised to the absorbance at 1550 cm-1, which is considered to be relatively insensitive
to peptide secondary structure.
3.2.3.5 Scanning Electron Microscopy
Hybrid hydrogels were dried via critical point drying using a Samdri-795 critical point drier,
mounted on aluminum Scanning electron microscopy (SEM) slides using carbon tape and then
sputter coated with gold for 2 minutes. The morphology of the hydrogels was then examined
using SEM (Leo1525 Gemini) at an accelerating voltage of 5 kV.
84
3.2.3.6 Cell Viability Studies
Passage 5 bone marrow derived mesenchymal stem cells (PromoCell) were cultured in human
mesenchymal stem cell (hMSC) growth medium (PromoCell) with 1% (v/v) anti-biotic/anti-
mycotic and 40,000 cells were seeded onto the scaﬀolds in the bottom of 96 well plates. 300
µL of hMSC growth media was added on top and changed every three days. After seven days
the samples were washed with PBS, fixed in 4% (v/v) formaldehyde for 15 minutes, then per-
meabilised with 0.1% (v/v) Triton-X. The samples were washed several times in PBS and then
incubated in the dark for 30 minutes with rhodamine phalloidin (Invitrogen) and DAPI (In-
vitrogen), used at 1:200 and 1:10,000 fold dilutions, respectively. The samples were washed
twice with phosphate buﬀered saline (PBS), and then placed on a glass cover slip, coated with
Prolong Gold (Invitrogen) and covered with a 12 mm circular glass cover slip. The Prolong
Gold was allowed to set for 24 hours, and then imaged with a LEICA SP5 MP inverted confocal
microscope, followed by image processing. Experiment performed by Dr. E. Thomas Pashuck
III.
3.3 Results and Discussion
3.3.1 b-Sheet Peptide Synthesis
The b-sheet peptide sequences (Figure 3.1) were rationally designed to contain a central region
comprised of amino acids that have a high propensity to form b-sheets. Isoleucine (Ile) and
Glutamine (Gln) were initially selected in this region, both being strong b-sheet formers due to
their bulky hydrophobic side groups [283, 284]. This central region was then synthesised to be
flanked by two Asp residues; these were included to oﬀer enhanced solubility of the hydrophobic
peptide core which alone would be completely insoluble in DI H2O. Three diﬀerent b-sheet
peptide sequences were synthesised with either six Ile (I6b) or Gln (Q6) residues in the central
b-sheet region, and to investigate how the length of the b-sheet eﬀects the properties of the
hybrid hydrogel a peptide with four Ile (I4b) residues was also synthesised. The design of these
peptide sequences allowed us to evaluate not only the eﬀects of the length of the b-sheet, but
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also how diﬀerent b-sheet forming amino acids and the peptide grafting density impacts on the
properties of the hybrid hydrogels.
Figure 3.1: Chemical structures of A) I4b, B) I6b and C) Q6 peptide sequences.
All peptide sequences were synthesised using a manual Fmoc/tBu strategy. The I4b peptide
was purified via reverse phase HPLC and peptide purity subsequently was confirmed via MALDI.
The corresponding HPLC chromatogram and mass spectra of the peptide can be viewed in Figure
3.2. The I6b and Q6 peptides were completely insoluble in water preventing a similar purification
process. The purity of the water insoluble I6b peptide was confirmed by analytical HPLC and
electronspray ionisation mass spectrometry (ESI) (Figure 3.3), similarly the purity of the Q6
was confirmed by liquid chromatography–mass spectrometry (LC-MS) (Figure 3.4).
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Figure 3.2: HPLC chromatogram and MALDI spectrum of I4b peptide.
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Figure 3.3: HPLC chromatogram and ESI spectrum of I6b peptide.
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Figure 3.4: LC-MS spectrum of Q6 peptide.
3.3.1.1 b-Sheet Peptide Characterisation
To verify that the peptide sequences formed b-sheet conformations CD was utilised, which is the
typical technique to identify the secondary structure of peptides and proteins [285, 286]. The
CD spectra for I4b, I6b and Q6 peptides at diﬀerent pHs can be viewed in Figure 3.5.
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Figure 3.5: CD spectra for A) I4b, B) I6b and C) Q6 diﬀerent b-Sheet peptides at diﬀerent pH.
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The assembly and formation of b-sheets is driven by intermolecular and intramolecular in-
teractions such as electrostatics, hydrophobic collapse, p-p stacking and hydrogen bonding. As
a result the formation of b-sheets is responsive to changes in pH, temperature and its solvent
environment [96, 93, 3]. It can be seen in Figure 3.5 that both the I4b and I6b peptides have
a CD signature with a negative minima at 220 nm in acidic and neutral pH conditions, which
is indicative of b-sheets formation. However, in basic conditions the CD signature of the I4b
peptide exhibits a change with a negative minima now present at 195 nm. This is characteristic
of the formation of a random coil and displays that the I4b peptide is responsive to pH with a
switch in secondary structure from b-sheet to a random coil in basic conditions. The I6b peptide
also starts to develop a peak at 195 nm in basic conditions, but still has a dominant minima
at 220 nm highlighting that even in basic conditions the I6b peptide still holds a strong b-sheet
structure and this is attributed with poor water solubility in basic conditions. The responsivity
of b-sheet formation to pH is likely caused by the aspartic acid residues, which contain a side
chain that is terminated with -COOH groups. These can be protonated or deprotonated at pH
values above their nominal values generating charges that can control electrostatic and hydrogen
bonding between neighbouring peptides, dominating the interactions and formation of b-sheet
between neighbouring peptides [97]. The pKa value for side chain -COOH terminal groups in
self-assembling peptides is likely to diﬀer significantly from the value of the free amino acid
in solution (pKa t 3.86) due to electrostatic interactions between neighbouring peptides and
charged side chains. Therefore, the deprotonation of the aspartic acid -COOH terminated side
chains is likely to occur at a much higher pH (pH > 7) and at which point the electrostatic
repulsive forces between adjacent -COO- groups in neighbouring peptides cause an increase in
the energy required to maintain peptide-peptide interaction and fundamentally results in the
dissassociation of the I4b peptide from b-sheet to a monomeric random coil. In the case of the
I6b peptide, the -COO- present in the Asp residues in the deprotonated state does not generate
enough repulsive force and favourable energy to cause a complete peptide-peptide dissociation
and thus the I6b peptide still maintains a strong b-sheet structure in basic conditions.
Comparitively the Q6 peptide sequence did not exhibit a characterisitic b-sheet signal in any
pH range with a negative minima at 195 nm, representing a random coil formation. Gln was
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trialed along Ile for the central b-sheet forming region of the peptide due to Gln natively being
a strong b-sheet former [283, 284], with the Gln side chains being known to interact strongly
in water via hydrophobic and complementary hydrogen bonding interactions to promote b-
sheet formation [97]. So it was unexpected that the Q6 peptide was not able to form b-sheets
under any pH range, especially when a similar peptide sequence with a Gln b-sheet core (P11-
I, Ac-QQRQQQQQEQQ-NH2) was successfully designed to adopt model b-sheet structures [3].
However, the P11-I sequence made use of Arg - Glu recognition to prevent random coil formation
[3], so there is a possibility that the -COOH side groups on the Asp residues present in the Q6
peptide did not provide enough favourable hydrogen bonding recognition when protonated to
generate the driving force required to assemble into a b-sheet arrangement. Furthermore, at
very low concentrations (< 0.01 mM) the P11-I peptide predominantly has a monomeric random
coil conformation [3], the CD measurements carried out on the Q6 peptide was performed at
1 mM so it is unlikely that concentration dependence was the contributing factor behind the
random coil conformation attributed to the Q6 peptide. As a consequence the Q6 peptide was
not investigated further to provide the desired b-sheet interactions.
There is also a diﬀerence in intensity of the CD signals for peptides investigated. Since these
peptides sequences are known to form hydrophobic b-sheet aggregates such as tapes, ribbons,
fibrils and fibres, there is likely to be diﬀerences in solubility across the bulk structures especially
at diﬀerent pH and thus a varying amount of scattering of the polarised light source, leading to
a diﬀerence in signal intensity.
3.3.2 Synthesis of Self-Assembled b-Sheet Peptide Hybrid Poly (g-glutamic
acid) Hydrogels
The synthesis of the hybrid hydrogels was performed as illustrated in Figure 3.6. b-sheet forming
peptide sequences were successfully conjugated to the g-PGA-H backbone with DIC in DMSO,
yielding a material (g-PGA-b-sheet) made entirely of peptide bonds. Under aqueous conditions,
the peptide grafts were expected to self-assemble, providing physical cross-links of the hydrophilic
polymer chain, resulting in the formation of a hydrogel. Two diﬀerent b-sheet sequences (I4b
and I6b) were grafted to the g-PGA-H backbone, as the Q6 peptide was not able to form b-
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sheet arrangements. These peptide sequences, however allowed us to evaluate the eﬀects of
both increasing the graft density and the length of the b-sheet on the properties of the hybrid
hydrogel. Following peptide conjugation, g-PGA-b-sheet was dialysed against water to form
hydrogels that are 9% g-PGA-b-sheet by weight.
Figure 3.6: Schematic of hybrid hydrogel synthesis and formation.
The degree of b-sheet peptide functionalisation was estimated via 1H-NMR (Figure 3.7 &
3.8). The functionalisation was evaluated from the comparison of the relative intensity of the
methyl groups present in the isoleucine residues (F, H) of the b-sheet peptide sequences and
normalised to the g-protons on the g-PGA-H. Using this ratio, peptide functionalisation was
estimated to be around 15% (g-PGA-15% I6b and g-PGA-15% I4b) or 7.5% (g-PGA-7.5% I6b).
93
Figure 3.7: 1H-NMR spectra and corresponding peak assignment of A) g-PGA-H, B) I4b peptide,
and C) g-PGA-15% I4b performed in DMSO-d6.
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Figure 3.8: 1H-NMR spectra and corresponding peak assignment of A) g-PGA-H, B) I6b peptide,
C) g-PGA-7.5% I6b and D) g-PGA-15% I6b performed in DMSO-d6.
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3.3.3 Characterisation of Self-Assembled b-Sheet Peptide Hybrid Poly ( -
glutamic acid) Hydrogels
3.3.3.1 Mechanical Characterisation
The mechanical properties of the hydrogels were studied using oscillatory shear rheology. In
this, the storage modulii (G’) (elastic component) and loss modulii (G’’) (viscous component)
were observed as a function of both oscillation frequency and strain. For all the materials that
formed hydrogels, the storage modulus exceeded the loss modulus, indicating the formation of
a gel. From the frequency sweeps (Figure 3.9A) it is seen that the mechanical properties of the
hybrid hydrogel are relatively independent of oscillation frequency. The mechanical properties
of the hydrogels remained in the linear elastic region up to strains of 1% with little change in
the storage modulus, however a significant decrease in storage modulus was observed at strains
of 10% (Figure 3.9B).
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Figure 3.9: A) Frequency sweep at 1% applied strain and B) Strain sweep at an oscillation
frequency of 6.283 rad s-1 of the hybrid hydrogels.
The mechanical properties of the hybrid hydrogels were found to be dependent on both the
b-sheet peptide graft density and the b-sheet region in the peptide sequence. The stiﬀness of the
hydrogels is seen in Figure 3.10A. Comparing the stiﬀness of g-PGA-7.5% I6b to g-PGA-15%
I6b shows that increasing the graft density doubled the storage modulus from ⇡ 27 kPa to ⇡
60 kPa. Increasing the number of isoleucine residues in the peptide sequence while keeping the
b-sheet graft density constant also increased the stiﬀness of the hydrogel by a third (⇡ 40 kPa
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to ⇡ 60 kPa). We found that it was possible to tailor the mechanical properties of the hydrogels
from ⇡ 27 kPa to ⇡ 60 kPa by changing the b-sheet length and graft density (Figure 3.10A).
These stiﬀnesses are in the region of many soft tissues and compare well to previously published
peptide-polymer hybrid hydrogel systems [158, 162, 11, 277]. One of the primary benefits of
using peptide-polymer hybrid-hydrogel systems is that the polymer backbone should help the
hydrogels remain in the gel state when exposed to significant strain.
One of the benefits of using peptide-polymer hybrid-hydrogel systems is that the polymer
backbone should help to reinforce the self-assembled b-sheets in the gel, helping the gel maintain
its mechanical properties when exposed to significant strain. The failure strain of hydrogel
systems can be defined as the point where the loss modulus surpasses the storage modulus, and
the gel becomes a viscous liquid [123]. In a similar manner to the stiﬀness of the hydrogels,
the number of isoleucine residues present in the b-sheet peptide sequence influenced the failure
strain. Reducing the number of isoleucine residues from six to four (g-PGA-15% I6b versus
g-PGA-15% I4b) results in a reduction in failure strain from ⇡ 25% to ⇡ 16%. In this case the
reduction in failure strain is thought to be due to a weaker physical bond provided by the shorter
b-sheet sequences. Since there are fewer b-sheet forming amino acids in the peptide, and fewer
amino acids in general, there will be fewer possible hydrogen bonds which give b-sheets their
strength. Weaker b-sheet are less able to resist applied forces and fail at lower strains. However,
the failure strains (16-25%) obtained for the hybrid hydrogels are suﬃcient to withstand the
strains exerted on them by a cellular environment and compare well to other popular peptide
based hydrogels.
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Figure 3.10: A) Storage moduli taken from strain sweeps at 0.1% Strain and oscillation frequency
of 6.283 rad s-1, ∗ # § signify p < 0.05 statistical diﬀerence between diﬀerent hybrid hydrogels.
B) Failure Strains taken from strain sweeps at the point where G’ surpasses G’’, ∗ # signify p
< 0.05 statistical diﬀerence between diﬀerent hybrid hydrogels.
In biological environments, materials will need to be able to withstand mechanical defor-
mation both from exogenous strains placed on the entire biomaterial, and the forces cells exert
on their local matrix. To further characterise the ability of our gels to recover from moderate
deformation, we placed them under a series of immediately increasing strains and monitored
the eﬀect on storage and loss moduli of the linear plateau. Figure 3.11 shows the evolution of
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storage moduli of the linear plateau of the hybrid hydrogels for these series of strain sweeps.
Up until strains reaching and surpassing the failure strain (⇡ 20%), all the hybrid hydrogels
showed losses in storage moduli of less than 25% (Figure 3.11). Once the failure strain was
surpassed, the storage modulus began to steadily drop for each individual sweep, with the final
values of the recovered storage modulus falling to around 70% of their initial value, which was
consistent across the diﬀerent hybrid hydrogel systems. This suggests that up until strains sur-
passing the failure strain, the hybrid hydrogels deform elastically and only once the failure strain
is surpassed do the hybrid hydrogels show permanent plastic deformation. For the individual
strain sweeps where the strain steadily increases past the failure strain, the plastic deformation
is gradual rather than catastrophic. We suspect that this is due to the geometry of the hybrid
hydrogel. The b-sheets domains are likely to be formed of an arrangement of many individual
peptide b-sheet strands located at diﬀerent points along the polymer backbone. When the gel
is strained beyond a certain point, the peptides which are being pulled the most by polymer
chains are likely to be first pulled away from the b-sheets, and as the strain increases more and
more peptides are removed, producing a gradual rather than a rapid decrease in mechanical
properties.
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Figure 3.11: Cyclic strain sweeps from (0.01% - 1, 2, 5, 10, 15, 20, 30, 50 and 100%), with a
point representing the last point of each strain sweep for A) g-PGA-15% I6b, B) g-PGA-7.5%
I6b and C) g-PGA-15% I4b.
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One of the primary benefits of using non-covalent rather than covalent interactions is the
ability of the bonds to reform after failure. Thus, after the application of high strains, the
hybrid hydrogels would recover their mechanical properties. To test this, individual sweeps up
to 200% strain were performed, followed by a 30 minute recovery period, and then another strain
sweep performed (Figure 3.12). This process was repeated twice, with the final storage moduli
reaching up to 93% of the moduli of the first strain sweep and there was also a large recovery
in the failure strains, which ranged from 81% and 100% of the first strain sweep. The ability
of these materials to self heal indicates that after the non-covalent b-sheets are ruptured during
large strains, they are able to reform in situ. The fact that they retain a larger percentage of their
initial mechanical properties after a 30 minute recovery period (at least 81%) versus immediate
strain to failure (around 70%) underscores the dynamic nature of the hybrid hydrogels, as the
b-sheets are able to adopt more energetically favorable, and mechanically robust, conformations
over time. This self-healing eﬀect and resistance to cyclic strain renders these hybrid hydrogels
ideal for biomedical applications which require recovery after significant deformation, such as
injectable therapies, or include cell types which exert significant strain on their environment.
Figure 3.12: Three repeat strain sweeps from 0.01 - 200% strain at an oscillation frequency
of 6.283 rad s-1 with a 30 minute recovery period in between each sweep for all of the hybrid
hydrogels
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3.3.3.2 Secondary Structure Verification
Circular dichroism was performed to probe the secondary structure of the hybrid hydrogels. In
previous work on similar polymer-b-sheet hybrid networks, CD revealed a similar signature CD
profile to that of a b-sheet conformation [287, 153, 156, 158], consisting of a minima at around
220 nm.  -PGA-H, as discussed previously, has its own secondary structure when ionised, which
is represented by a CD spectra consisting of a minimum at 206 nm and a positive maximum
just below 195 nm (Figure 3.13). Following molecular dynamic studies this is thought to have a
left hand helical formation [253, 266, 268, 269, 267, 270].
Following b-sheet peptide conjugation, the CD had a minimum between around 220-230 nm,
thought to be representative of a b-sheet conformation of the attached peptide. The change in
CD suggests that the b-sheet grafts not only contribute themselves to the CD signal, but also
change the signal of the polypeptide backbone. For the g-PGA-15% I6b and g-PGA-7.5% I6b
materials, the CD signals display a red shift of around 5 and 10 nm respectively in the 220nm
minima associated with a typical model b-sheet conformation. When considering the secondary
structure of g-PGA-H grafted with b-sheet peptides in comparison to that of model b-sheet
peptide sequences, the inherent secondary structure of the polymer backbone is likely to impose
more unique and increasingly twisted b-sheet arrangements, making the interpretation of the
hybrid hydrogel’s secondary structure diﬃcult. Previous studies indicated that a red-shifted
b-sheet in CD is indicative of a more twisted b-sheet geometry [288, 255], and increases in red-
shift is represented in more twisted or distorted b-sheets. In most b-sheet peptide systems, the
b-sheet peptides are free to adopt the most favorable b-sheet geometry. However, in our system
these peptides are covalently bound to a high molecular weight polymer backbone, so the actual
forces of the b-sheet will be a combination of optimal hydrogen bonding arrangements of the
peptides within the sheet, and the forces placed on the peptides by the polymer backbone. As
seen in Figure 3.13, the g-PGA-7.5% I6b hydrogel has the most red-shifted b-sheet spectrum.
We believe that this is because it has half the peptide functionalisation density as the other
two hydrogels, which means it has significantly less peptides per volume. This means that for a
b-sheet comprised of the same numbers of peptides, the g-PGA-7.5% I6b system would require a
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larger volume of hydrogel, and peptides attached to more distant g-PGA chains, which are likely
to place more strain on the b-sheet. An increase in b-sheet twisting, has a negative eﬀect on the
hydrogen bonds on the periphery of the b-sheet, increasing the distance between hydrogen bonds
and weakening the b-sheet [289, 290]. Comparing the stiﬀness of the diﬀerent hybrid hydrogels
(Figure 3.10) to the CD signals (Figure 3.13), in the case of the g-PGA-7.5% I6b hydrogel which
exhibits the greater red-shift and the lowest stiﬀness highlights that an increase in disorder or
twisting of the b-sheet provides a weaker hybrid hydrogel.
There is also a diﬀerence in intensity of the CD signals in the hybrid hydrogels investi-
gated. Since these structures are essentially a highly hydrophilic polymer chain crosslinked
via hydrophobic b-sheet aggregates there is likely to be diﬀerences in solubility across the bulk
structures and thus a varying amount of scattering of the polarised light source, leading to a
diﬀerence in signal intensity.
Figure 3.13: CD spectra for g-PGA-H and the diﬀerent hybrid hydrogels.
To further confirm the secondary structure of the g-PGA-b-sheet, we incubated the hy-
brid hydrogels with ThT, a bensothiasole which shows increased fluorescence when binding
b-sheets[291]. This method has the advantage of having low background from other polypeptide
secondary structures. The fluorescence spectra for the ThT binding studies can be viewed in
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Figure 3.14. When bound to b-sheet fibrils, The solution was excited at a wavelength of 440nm
and the emission spectra was recorded, with a peak at 485nm indicating the presence of b-sheets
[292, 293]. Fluorescence emission spectra of the ThT in the presence of hybrid hydrogels showed
an enhancement in fluorescence at 485nm compared to g-PGA-H. The emission intensity also
correlated with the b-sheet graft density, with a greater emission present in the g-PGA-15%
I6b versus the g-PGA-7.5% I6b. Increasing the length of the b-sheet sequence also increased
fluorescence intensity, with the g-PGA-15% I6b having a more intense fluorescence than the g-
PGA-15% I4b. To verify that b-sheet structures were responsible for the ThT signal, the hybrid
hydrogels were incubated with 6M guanidinium chloride (GndCl), a b-sheet denaturant, and the
resulting spectra show a significant loss of the 485nm peak for all the hybrid hydrogels.
Figure 3.14: ThT binding studies for g-PGA-H and the diﬀerent hybrid hydrogels.
FT-IR was used to further verify the presence of the b-sheet secondary structure in the hybrid
hydrogels (Figure 3.15). The amide I peak from 1610 - 1690 cm-1 was investigated, the spectra
in this region was normalised to the amide II peak at 1550 cm-1 which is relatively insensitive
to peptide secondary structure [102]. The prominent peak at 1630 cm-1 displayed in all the
synthesised hybrid hydrogels is indicative of a b-sheet conformation[294, 295] and is not visibly
present in the g-PGA-H spectra.
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Figure 3.15: FT-IR spectra of the amide I region (1550-1700 cm-1) for g-PGA-H and the diﬀerent
hybrid hydrogels.
3.3.3.3 Scanning Electron Microscopy
All hybrid hydrogels were dehydrated via critical point and imaged using SEM. The SEM images
showed that all the hybrid hydrogels have a highly porous structure formed from a connected
network of short fibers of around 500 nm in length as shown in Figure 3.16. There was no
obvious diﬀerence in morphology between the hybrid hydrogels.
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Figure 3.16: SEM images of A) and B) g-PGA-15% I6b, C) and D) g-PGA-7.5% I6b, and E)
and F) g-PGA-15% I4b.
3.3.3.4 Cell Viability Studies
In order to better understand the biocompatibility of the hybrid hydrogel, human mesenchymal
stem cells (hMSCs) were seeded onto the hydrogels and cultured for seven days. As can be
seen in Figure 3.17A, the cells adhere and spread on the hybrid hydrogels, suggesting that
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they promote cell adhesion even though they lack added cell adhesion sequences. However,
cells can produce their own extra cellular matrix, and by providing a biocompatible matrix
for cell encapsulation the hybrid hydrogels allow the stem cells to synthesise their own milieu.
Furthermore, we additionally functionalised 1% of the carboxylic acids on the g-PGA-15% I6b
network with an RGD cell adhesion epitope. As seen in Figure 3.17B, these gels support the
survival and adhesion of hMSCs. These results suggest that these hybrid hydrogels are a suitable
platform for cell encapsulation and are able to be modified with bioactive sequences that can be
tailored to specific biological applications. Experiment performed by Dr. E. Thomas Pashuck
III.
Figure 3.17: Confocal images of hMSCs after 7 days in culture, seeded on A) g-PGA-15% I6b
and B) g-PGA-15% I6b + 1% RGD hydrogels. (Image processing performed by Dr. E. Thomas
Pashuck III)
3.4 Conclusions and Future Work
In this chapter b-sheet peptide-polymer hybrid hydrogels formed entirely from peptide bonds
were synthesised and evaluated. We found that it was possible to tailor the stiﬀness of the
hydrogels using the b-sheet peptide graft density and the number of isoleucine residues present
in the peptide sequence, this range of stiﬀnesses achieved compares well to other peptide self-
assembled hydrogels such as the peptide-amphiphile [122, 123] and b-sheet hairpin systems [80].
When comparing these values to the other hybrid hydrogels of similar design, the attributed
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stiﬀnesses far surpasses both the b-sheet and coiled-coil self-assembled peptide-polymer hybrid
systems in which from the rheological studies had stiﬀnesses around 100 - 400 Pa depending on
gel concentration and composition [158, 162, 11, 277]. The b-sheet peptides domains were found
to provide strong physical cross-links and robust properties, attributed with high failure strains
of around 16-25% depending on composition, this is far superior to both any hybrid hydrogel or
peptide self-assembled system which tend to fail at  2%, much less than what cells will typically
exert on their local environment [227]. Further rheological studies also displayed that b-sheet
peptides can provide resistance to cyclic strain and following material failure, the reassembly of
b-sheet domains can induce a “self-healing” eﬀect following a rest period. Probing the secondary
structure of the hybrid hydrogels via various techniques gave indication and verification of the
formation of b-sheet arrangements. Also, being composed entirely from natural peptide units,
the hybrid hydrogels should be able to match the biocompatibilty of other self-assembled peptide
hydrogels and we found that hMSCs had excellent cell viability after seven days in culture. With
gelation occurring at a low b-sheet graft density (  10%), it was demonstrated that we can
easily functionalise the polymer network with further peptide modifications, with an additional
1% RGD conjugated to the network. Having this capability is highly desirable as it allows these
hybrid hydrogels to be functionalised with a variety of biomolecules and when combined with the
tunable mechanical properties previously discussed, these hydrogels should act as an excellent
platform for the targeting of the regeneration of a variety of diﬀerent tissue types. In light of
all these properties, these self-assembled polymer-b-sheet peptide hybrid hydrogel systems act
as an excellent and interesting platform for future tissue engineering scaﬀolds and biomedical
applications.
With these hybrid hydrogel networks having the ability to tune the mechanical properties
and be easily functionalised with additional bioactive epitopes, in the future this platform can
be engineered towards applications directed for specific tissue types. In consideration of the
properties previously discussed, with the platform providing excellent resistance to cyclic strain
and “self-healing”, renders these systems ideal for the mechanical matching of tissues with repeat
loading cycles. The ability to tailor the stiﬀness between 25 kPa - 60 kPa immediately falls in
the region of which hMSCs preferentially diﬀerentiate into osteogenic lineage, the physiological
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stiﬀness of most muscle types and the stiﬀness of the pericellular matrix of cartilage [296],
opening up these hybrid hydrogels to a whole range of tissue types without any further tailoring.
With the g-PGA-H polymer network containing a large majority of -COOH even after b-sheet
conjugation, means that the hybrid hydrogels polymer network could potentially have natural
bone bonding bioactivity, which is thought to be enhanced by the presence of high density of -
COOH groups which promote the formation of an apatite layer in vivo [297, 298, 299]. However,
with the stiﬀness of collagenous bone is in the region of 100 kPa [296], therefore the hybrid
hydrogels may require further optimisation to achieve stiﬀness in this region.
Investigating the secondary structure of the hybrid hydrogels by conventional laboratory
based techniques such as CD, FT-IR and ThT binding studies gave indication of the formation
of b-sheet arrangements but this system has an inherently complex architecture, arising from a
polymer backbone that has a native helical arrangement [253, 266, 268, 269, 267, 270], which is
then further organised by the presence of b-sheet domains to form hybrid hydrogel networks. This
means many questions are left unanswered about the molecular structure of the systems imposed
by diﬀerent compositions of b-sheet graft density and sequences, and how this then correlates
to the attributed mechanical behaviour. To fully understand this relationship, it is essential to
gain insight into how the b-sheets assemble in these systems both in terms of the size and spatial
density distribution of these domains. As well, an investigation into the possibility that the
b-sheet sequences can fold co-operatively with the polymer backbone to create macromolecular
structures, that may give reason as to why our system far surpasses the mechanical properties
of other hybrid hydrogel systems of similar architecture. To determine this correlation it would
require investigations using small angle neutron scattering (SANS), which has previously been
used succesfully on similar materials [300, 301, 302, 157, 303, 304, 305, 306] to illuminate the
architecture of the self-assembled b-sheet hybrid hydrogels and then correlate the relationship to
the mechanical properties already determined. To use SANS technique succesfully it would be
essential to synthesise a variety of hybrid hydrogel networks with normal and deuterated b-sheet
sequences combined with systematic length and grafting density alterations, and then utilise any
contrast-variation to try determine the factors that provide these diﬀerent mechanical properties.
Understanding this relationship on a fundamental level may also help with the translation of
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the hybrid hydrogel and the principles of its molecular architecture to other future system and
applications.
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Chapter 4
“Smart” Self-Assembled b-sheet
Peptide Nano-Hybrid Hydrogels
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4.1 Introduction
Having successfully synthesised and characterised b-sheet self-assembled hybrid hydrogels, it was
sought to demonstrate how versatile these materials are as a platform, displaying the capability
to incorporate diﬀerent functionalities. In the previous chapter, it was shown that additional
peptide sequences could be grafted in an attempt to help promote cell adhesion. The aim of this
study was to demonstrate that the hydrogels could be used as a delivery platform for potential
in vivo sensing applications, an area largely unexplored for hydrogel applications.
Matrix metalloproteinases (MMPs) regulate various aspects of cell processes; they function
in the extracellular environment of cells and are often secreted or anchored to the cell surface
to degrade both matrix and non-matrix proteins. They typically play central roles in morpho-
genesis, wound healing, tissue repair and remodel in the response to injury [307]. They play
fundamental roles in prevention and also the progression of diseases such as cancer and arthritis
[308, 309]. MMPs are not typically expressed in normal healthy tissue, only in diseased or in-
flamed tissue, and their expression patterns and quantities depend on cell/tissue type, diseases,
inflammatory conditions and the tumor itself, being controlled by specific signals [307]. With
this in mind, one potential area of interest to recognise and sense for in vivo is the state of
inflammation and immunity following an injury or joint replacement, giving additional feedback
and information at that site in the body.
Inflammation and immunity is controlled by several individual MMPs, namely, MMP-7 which
is up-regulated in any disease that involves inflammation. Although MMP-7 has an indirect part
in killing bacteria, it is highly sensitive to the presence of virulent bacteria and is thought to
be a physiological signal for microbial infection [310, 311]. In terms of its role in response to
inflammation, MMP-7 helps develop favourable chemokine gradients that in turn results in the
influx of inflammatory cells [312] and also activates cytokines such as tumor necrosis factors
[313], which function in inflammation and repair processes with such an active role in these
processes, renders MMP-7 as an excellent marker for inflammation and immunity.
QDs are semiconductor nanocrystals with size-dependent optical properties and have many
attractive properties for sensing applications including a strong resistance to photo-bleaching,
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narrow emission and a wide excitation spectrum in the UV range [173, 210]. Activity-dependent
FRET-based QD-peptide sensors have been used to detect cleavage events for many diﬀerent en-
zymes [14, 203, 17, 18, 16, 204, 15, 205, 206]. They have a narrow and tunable emission, and with
donor/acceptor spectral overlap easily optimised which makes QDs ideal FRET donors. Specifi-
cally for the detection of MMP-7, Kim et al utilised a QD-AuNP system, in which AuNP-labeled
peptide substrates were bound to QDs via streptavidin-biotin coupling. The photoluminescence
(PL) of the QD donor was subsequently quenched via the absorption of the AuNP and in the
event of the protease-mediated cleavage of the peptide, resulted in the dissociation of the AuNPs
and the PL of the QDs was subsequently recovered [15]. QDs immobilised into hydrogel net-
works and used in sensing applications have also been investigated [226, 220], however most work
has been centered around strategies for the incorporation of QDs into hydrogel networks rather
than their resultant applications. The immobilisation of QDs into hydrogel networks typically
involve two strategies, either through physical non-covalent interactions or covalent attachment.
The challenge associated with incorporation of QDs into hydrogel networks is to maintain the
stability of QDs and preserve their optical properties. Non-covalent approaches have the prin-
cipal advantage of high concentration of QD encapsulation but with a lack of control over the
diﬀusion process, and the interactions between QD and polymer network can result in aggrega-
tion, diminishing the QD luminescence [213, 214, 215]. Covalent strategies require the QDs to
be chemically tailored which often requires tedious polymerisation or ligand exchange processes
[215], so in light of this, a combination of both approaches would provide the advantages of
high doping capacity from diﬀusion with stability from firm immobilisation. Biotin-streptavidin
coupling, although not strictly a covalent bond, has a high infinity and specificity, coupled with
an incredibly low dissociation constant (KD u 10 15M) providing a desired strong interaction,
helping to maintain QD stability when immobilised. It has been successfully used to simulta-
neously incorporate QDs into polymer networks and functionalise peptides on the QD surfaces
[218].
In this chapter, QD biosensors for MMP-7 are immobilised inside the b-sheet self-assembled
hybrid hydrogels and used for the detection of MMP-7 activity (Figure 4.1). Initially a QD
assay for MMP-7 was developed based on the MMP-7 specific peptide cleavage substrate NH2-
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RPLALWRSGGGK(Biotin)-CONH2 (BMMP). The peptide sequence was designed to contain a
biotin labelled lysine N-terminus that forms a streptavidin-biotin coupling interaction with strep-
tavidin conjugated QDs. A NHS-QSY9 dye quencher was coupled to the opposing C-terminal
amine of the BMMP peptide sequence and was selected along with 565nm QD streptavidin
conjugates (SA-QDs). QSY9 has an ideal absorption profile with a maximum at 563 nm which
results in a complete spectral overlap with the SA-QDs and renders it an ideal FRET quencher
for this system. Similarly to previously discussed systems, the protease-mediated cleavage of
the BMMP peptide substrate, the QSY9 dissociates and the PL of the QDs is recovered. Once
optimised, these sensors were immobilised inside the b-sheet self-assembled hybrid hydrogels via
diﬀusion and bound to the polymer network by the same streptavidin-biotin coupling strategy.
To facilitate this desired sensor immobilisation, an additional 1% of -COOH groups on the poly-
mer backbone were functionalised with a biotin labelled lysine via the DIC mechanism used in
the previous chapter.
Figure 4.1: Schematic of the MMP-7 mediated FRET based peptide-QD conjugate assay and
the immobilisation of this assembly into the b-sheet self-assembled g-PGA-H hybrid hydrogel
platform via streptavidin-biotin coupling.
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4.2 Materials and Methods
4.2.1 MMP-7 Sensor Design
4.2.1.1 Peptide Synthesis
All peptide sequences were synthesised using a manual solid-phase method previously described
with all reagents obtained from AGTC bioproducts. The peptide sequence BMMP and a simi-
lar sequence Ac-HHHHHHGGGSRWLALPRK (MMP), based on a known MMP-7 cleavage se-
quence was purified using a prep reverse scale HPLC. The peptides were dissolved at 5 mg/mL
in a solution of 95% DI H2O, 4.9% acetonitrile, 0.1% TFA and purified with a mobile phase
gradient of 95% DI H2O and 5% acetonitrile to 95% acetonitrile with a Phenomenex Gemini-NX
prep column. Peptide fraction identities were verified via MALDI courtesy of the Chemistry De-
partment, Imperial College London, using a MALDI micro MX (Micromass, Manchester, UK).
Once purified the BMMP and MMP peptides were dissolved in anhydrous DMF at 5 mg/mL
and reacted with an NHS-QSY9 quencher (Invitrogen) at a 2:1 (BMMP/MMP:NHS-QSY9) mo-
lar equivalence. The resultant solution was then diluted with a solution of 95% DI H2O, 4.9%
acetonitrile and 0.1% TFA. Similarly, the dye conjugated peptides (BMMPD and MMPD) were
subsequently purified with a mobile phase gradient of 95% DI H2O and 5% acetonitrile to 95%
acetonitrile and using the same Phenomenex Gemini-NX prep column. The resultant peptide
fraction identities were verified via LC-MS.
4.2.1.2 Enzyme Reactions
To investigate the recognition and cleavage of the synthesised MMP-7 peptide substrate, 5
mg of the BMMP peptide was incubated with the MMP-7 enzyme at a molar ratio of 100:1
BMMP:MMP-7 in a reaction buﬀer of 15 mM HEPES, 150 mM NaCl and 5 mM CaCl2 to
achieve a final peptide concentration of 5 mg/ml. The reaction was left to propagate for 6 hours
at 300rpm and 37º C. After, the resultant solution was then filtered using a centrifuge filter
with a MWCO 10,000 Da (Millipore) to remove the enzyme, and diluted with a solution of 95%
H2O, 4.9% acetonitrile and 0.1% TFA. The subsequent enzymatically cleaved fractions were
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then verified via HPLC, using a mobile phase gradient of 95% DI H2O and 5% acetonitrile to
95% acetonitrile and a Phenomenex Gemini-NX semi-prep column.
4.2.1.3 Quantum Dot MPA Exchange
Core/shell CdSe/ZnS 565nm QDs (565-QDs) were purchased from Invitrogen and received at
a known concentration in decane. To allow for peptide modification, the QDs were first phase
transferred to an aqueous solution by an MPA ligand exchange. An aliquot of QDs was diluted
in decane to achieve a 1 mL solution of 100 nM. Separately, 5 mg of a previously prepared MPA
Na+salt was dissolved in 1 mL of formamide, and added to the QD solution in a 4 mL glass
vial and vortex vigorously. The solution was then centrifuged for 10 minutes at 5000 rpm and
the QDs visualised under 365 nm illumination provided by a hand-held UV lamp, appearing to
transfer completely into the formamide phase. The aqueous phase was extracted and added to
10 mL of 10 mM borate buﬀer (pH 8.5). The formamide/aqueous phase was then subjected
to three cycles of 10-fold concentration/dilution using a 10 kDa MWCO ultrafiltration units
(Millipore) at 4000 g for 10 minutes. The final concentration of the QDs was determined from
the absorption intensity of the absorption onset peak in the UV-visible absorption spectra ( "532
= 139,000 M-1cm-1, Invitrogen information). The MPA-capped QDs were then stored in the
dark at 4°C until required.
4.2.1.4 FRET Quenching
The purified BMMPD and MMPD peptides were dissolved in a working buﬀer consisting of
15 mM HEPES, 150 mM NaCl, 5 mM CaCl2 and 0.01% w/v bovine serum albumin (BSA)
pH 7.4 at a concentration of 10 µM. The exact concentration of the BMMPD and MMPD
buﬀer solution was calculated from UV-Visible absorption spectra, taking the absorbance and
extinction coeﬃcient of the QSY9 quencher at 563nm (" = 88,000 M-1cm-1) using a Perkin
Elmer LAMBDA 25 spectrophotometer (Waltham, MA). The MPA-capped 565-QDs in 10 mM
borate buﬀer (pH were prepared as previously described. The borate buﬀer was then exchanged
for the working buﬀer, using a similar 10-fold concentration/dilution ultrafiltration process as
previously described. The final 565-QDs concentration was checked via the absorption onset peak
117
in the UV-visible absorption spectra. Quantum Dot 565nm Streptavidin Conjugates (SA-QDs)
were purchased from Invitrogen and used as received. From the stock solutions, the 565-QDs
and SA-QDs were diluted with varying concentrations of the MMPD and BMMPD peptide
respectively to achieve diﬀerent molar ratios of peptide:QD and the solutions vortex rapidly to
obtain final homogenous solutions of 25 nM 565-QDs and SA-QDs. The solutions were left to
sit for 30 minutes to allow for histag self-assembly and biotin-streptavidin association between
the diﬀerent peptide and QDs solutions. The corresponding quenching from diﬀerent peptide
concentrations was recorded using steady state photoluminescence emission spectra at room
temperature with a Jobin Yvon FluoroMax-4 Flourimeter. The initial solutions were further
diluted and spectra recorded using a 120 µL quartz three-window fluorescence cuvette. Samples
were excited at 400 nm with a 5 nm excitation/emission and 0.2 s integration time. The acquired
spectra were corrected for variations in lamp and detector eﬃciency with files from Jobin Yvon.
4.2.1.5 Enzymatic Assay
Recombinant, human and activated MMP-7 (Calbiochem, La Jolla, CA) was purchased and once
received the enzyme was diluted in a buﬀer of 15 mM HEPES, 150 mM NaCl, 5 mM CaCl2 and
0.01% w/v BSA pH 7.4 into single use aliquots stored at -80 °C. Typically a stock solution of
quenched 25 nM 565-QDs and SA-QDs were prepared by diluting the QDs with either a MMPD
or BMMPD solution (15 mM HEPES, 150 mM NaCl, 5 mM CaCl2 and 0.01% w/v BSA pH 7.4)
and vortexed so that the final concentration of peptide:QD ratio was either 25:1 for the 565-QDs
or 80:1 for the SA-QDs. The QDs-peptide stock solutions were left to associate for 30 minutes
and then aliquoted into polypropylene tubes of 40 µl. 10 µL dilutions (50, 100, 1000 and 5000
ng/mL) of the MMP-7 enzyme was then added to each 40 µL QD aliquot and agitated for 3
hours at 300 rpm and 37 °C. After, 5 µL of each reaction solution was diluted in 120 µL DI
H2O and the steady state photoluminescence emission spectra read at room temperature with
a Jobin Yvon FluoroMax-4 Fluorimeter previously described.
In parallel, a similar quenched 25 nM SA-QDs QD:BMMPD solution was prepared with the
same 80:1 BMMPD:QD ratio and aliquoted into 40 µL samples. 10 µL of MMP-7 enzyme was
then added to each 40 µL QD aliquot so that the final diluted enzyme concentration was either
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5000 ng/mL or 100 ng/mL. 5 µL of each reaction solution was then removed at 15, 30, 45, 60, 120
and 180 minute time points, diluted in 120 µL DI H2O and the steady state photoluminescence
emission spectra read at room temperature with a Jobin Yvon FluoroMax-4 Fluorimeter as
previously described.
4.2.2 Synthesis of Polymer-b-sheet-Biotin
g-PGA-H was prepared as previously described. Similarly to the previous chapter the lyophilised
product was then dissolved at a known concentration (5 wt%) in DMSO at 80 °C whilst stirring
until a completely clear solution was obtained. The carboxyl groups of the g-PGA-H solution
were then activated in the presence of DIC at a molar equivalence of 20% and left to stir for
24 hours. Next, the I6b peptides were first dissolved in TFA, dried under vacuum and then
re-dissolved in DMSO at 5 wt%. Finally the I6b peptides and a deprotected Lys-Biotin both in
DMSO are added to the DIC functionalised g-PGA-H solution at the desired equivalences, and
left to conjugate under stirring for 24 hours. After coupling for 24 hours the DMSO solutions
were then dialysed (using a Spectrum Labs regenerated cellulose membrane, MWCO 8,000 Da)
against DI H2O for 3 days, with the dialysis media changed twice daily. The hybrid hydrogels
formed complete gel structures in the dialysis bags after a couple of hours in dialysis.
4.2.3 Synthesis of Polymer-b-sheet-QD
4.2.3.1 Quantum Dot Immobilisation Studies
To verify the stability of the SA-QDs immobilised into the g-PGA-B hydrogel networks, hydro-
gels were synthesised with a 15% I6b (g-PGA-9% I6b) and no additional biotin functionalisation,
in the presence of DIC as previously described. Individual 40 µl g-PGA-15% I6b and g-PGA-B
hydrogels were then incubated overnight in 100 µL of 50 nM QD solution and rocked at 60 rpm
to immobilise the QDs into the hybrid hydrogel network. The remaining solution was removed
and gels washed twice thoroughly with the QD-enzyme reaction buﬀer (15 mM HEPES, 150
mM NaCl, 5 mM CaCl2 and 0.01% w/v BSA pH 7.4). The resultant hydrogels were then left
in sealed polypropylene tubes for 24 hours and the emission spectra was then read by exciting
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at 400 nm and recording the emission spectra from 500 to 650 nm at 2 nm intervals, using a
SpectraMax M5 microplate reader (Molecular Devices, Wokingham, UK).
4.2.3.2 Synthesis of g-PGA-QD
Following gelation of the g-PGA-B hydrogels, individual 25 µL gels were then incubated in
100 µL of the QD-enzyme reaction buﬀer (15 mM HEPES, 150 mM NaCl, 5 mM CaCl2 and
0.01% w/v BSA pH 7.4) overnight and then the remaining solution removed. A stock solution of
quenched 50 nM QDs was prepared by diluting the received QDs with a BMMPD solution and
vortexed so that the final concentration of peptide:QD ratio was 80:1. The individual hydrogels
were then incubated overnight in 100 µL of the QD/BMMP solution and rocked at 60 rpm
to immobilise the QDs into the hybrid hydrogel network. In a similar manner, the remaining
solution was removed and gels washed twice thoroughly with the QD-enzyme reaction buﬀer,
resulting in the final immobilised QD MMP7 sensors incorporated within the hydrogel network
(g-PGA-QD).
4.2.4 Characterisation of “Smart” Self-Assembled b-sheet Peptide Nano-Hybrid
Hydrogels
4.2.4.1 Enzymatic Assay
Following QD encapsulation and washing, the g-PGA-QD hydrogels were weighed and placed
into individual wells of a black/clear bottomed 96 well plate. The initial emission spectra was
recorded before the enzyme addition, by exciting at 400 nm and recording the emission spectra
from 500 nm to 650 nm at 2 nm intervals, using a SpectraMax M5 microplate reader (Molecular
Devices, Wokingham, UK). 100 µL enzyme solutions were prepared, so that when added to the
g-PGA-QD hydrogels the final enzyme concentration would be 5000 ng/mL taking into account
the aqueous content of the hydrogel. For controls, 100 µL of QD-enzyme reaction buﬀer was
added to the g-PGA-QD hydrogels instead of an enzyme solution, and also repeated with both
enzyme and buﬀer additions to g-PGA-B hydrogels, not containing QDs labelled with MMP-7
peptide substrates. Following enzyme additions, the enzyme reactions were allowed to propagate
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for 6 hours under gentle agitation (60 rpm) at 37 ºC. After the emission spectra was read again
by exciting at 400 nm and recording the emission spectra from 500 nm to 650 nm at 2 nm
intervals, using the microplate reader. Finally, the emission spectra was then normalised by the
weight of each hydrogel yielding the final emission spectra.
4.2.4.2 Rheological Studies
All rheological studies were preformed on a TA-AR200 rheometer using a 8mm parallel plate
with a 0.5 mm gap distance at 25 °C on 40 mL hydrogel samples. Frequency sweeps were
performed at 1% strain fixed with a varying oscillation frequency of 0.1 – 100 rad s-1. Strain
sweeps maintained a fixed oscillation frequency of 6.283 rad s-1 and variable applied strain of
(0.01 – 200%). For the recovery experiments three identical strain sweeps were performed in
series with a 30 minute soak time in between each strain sweep.
4.3 Results and Discussion
4.3.1 MMP-7 Sensor Design
4.3.1.1 Peptide Synthesis and Quencher Labeling
Quenching acceptors are popular in FRET systems because they have the advantage of being able
to eliminate the background fluorescence which can originate from direct acceptor excitation or
re-emission [173]. Within the system, the QD sensor is operating inside a hydrogel network and
with QD emission likely to scattered especially with b-sheet aggregate domains, so in attempt
to reduce any background fluorescence a quenching acceptor was chosen over an organic dye
acceptor. Two key components of the FRET process is the extent of the spectral overlap between
emission wavelengths of the donor and the absorption wavelengths of the acceptor molecule,
coupled with the distance between donor and acceptor. A QSY9 quenching acceptor was selected
along with QDs with an emission of 565 nm; QSY9 has a maximum absorption at 563 nm
resulting in a complete spectral overlap (Figure 4.2) and rendering it an ideal quencher to be
coupled with these QDs.
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Figure 4.2: Normalised absorption/photoluminescence spectra for QD565, and normalised ab-
sorption spectra for QSY9.
The QSY9 dye was coupled to the BMMP substrate via NHS-amine coupling and purified
via HPLC to remove any unbound dye or unreacted peptide. HPLC traces of the final BMMP
and BMMPD peptides along with their peptide purities can be viewed in Figure 4.3. After
purification both peptide substrate and quencher labelled peptide have a single sharp peak and
exact mass units of their predicted molecular weights verifying their identity.
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Figure 4.3: A) HPLC chromatograms for BMMP and BMMPD, B) MALDI Spectra for BMMP
and C) LC-MS Spectra for BMMPD peptides.
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To determine that the peptide substrate could be recognised and cleaved by the MMP-7
protease, the BMMP substrate was incubated with the MMP-7 enzyme for a period of 6 hours.
Following incubation, the resultant BMMP solution and its cleaved fractions were separated by
HPLC (Figure 4.4). From the chromatogram, it is evident that there is a large central peak
(labelled b) and representative of the uncleaved BMMP peptide. Either side two other peaks
(a and c) are present thought to be the cleaved fractions, which were not visible in the initial
BMMP chromatogram, verifying that the BMMPD peptide can be recognised and cleaved by
MMP-7.
Figure 4.4: HPLC chromatograms for BMMP and MMP-7 cleaved BMMP peptides.
4.3.1.2 Peptide Conjugation and FRET Quenching
In previous studies, derivatisation of QDs with biological molecules have involved numerous
strategies from EDC/NHS covalent coupling, electrostatic or metal-aﬃnity-driven self-assembly
and biotin-avidin chemistry [210]. With these strategies in mind, the QD sensors were designed
to have a self-assembly driven peptide conjugation to the QD surface. The BMMPD peptide
was synthesised to contain an appending histag sequence (MMPD) instead of the terminal biotin
lysine. This strategy in previous work has been found to be versatile and robust, and has been
applied to assemble a variety of peptides and proteins on QD surfaces [17, 16, 14, 18]. A two
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staged-process was employed, involving a phase transfer of the QDs to an aqueous solution
followed by the peptide modification (Figure 4.5A).
Figure 4.5: Diﬀerent QD assay strategies. A) His-tag self-assembly and B) Streptavidin-biotin
coupling.
This strategy proved to have a good quenching eﬃciency with only 25:1 peptide:565-QD
ratio required to achieve t 82 % quench in QD PL (Figure 4.6A). However, following incubation
with the MMP-7 enzyme, no recovery in PL could be achieved and is discussed later. The
assay was subsequently redesigned to utilise streptavidin-biotin site specific coupling (Figure
4.5B). The most important factor regarding the rate of energy transfer of FRET is the distance
between the donor and acceptor. Whilst a streptavidin-biotin coupling strategy provides non-
specific substrate binding, in this case it has a negative aﬀect on FRET eﬃciency, increasing
the distance between the QD surface and the quencher. This reduction in eﬃciency can be
estimated by the FRET equation (Equation 1.4), the two diﬀerent coupling strategies and their
corresponding eﬃciencies are summarised in Table 4.1.
Experimentally, diﬀerent molar ratios of BMMPD:SA-QD were left to associate and the
steady state PL of the resultant solutions measured (Figure 4.6). It is apparent that the increased
distance between donor and acceptor inherent of the streptavidin-biotin coupling has a negative
eﬀect on the FRET eﬃciency, with a suﬃcient quenching of QD PL occurring at around 85:1
BMMPD:QD ratio providing an overall t 82 % quench in QD emission. With this in mind a
80:1 BMMPD:QD ratio was selected for the optimised enzymatic assay. This ratio was chosen
as it can be seen experimentally that the QD PL is quenched upto a ratio of 100:1 BMMPD:QD
(Figure 4.6), this additional quenching suggests that there is a possible 100 available sites on
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the QD for biotin-streptavidin interactions to occur. Therefore, at a ratio of 80:1 BMMPD:QD
approximately 20 potential coupling sites will be left on the QD surface to be bound to the
biotin functionalised g-PGA-b-sheet hydrogel networks.
Figure 4.6: Steady-state photoluminescence spectra following the conjugation of the QSY9
quencher labelled peptides to A) QD565 and B) 565 nm SA-QDs at diﬀerent concentrations.
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Donor Acceptor rt (nm)a R0(nm)b QE (%)c re(nm)d
SA-QD (565 nm) QSY9-RPLALWRSGGGK(biotin) 11.82 5.96 45.24 10.89
565-QDs Ac-(His)6GGGSRWLALPRK-QSY9 6.82 5.96 95.73 7.44
Table 4.1: aTheoretical estimated maximum distance (rt) from the core of the QD to the surface
of QSY9. bThe Forster distance (R0) values of QD-QSY9. c The quenching eﬃciency (QE) from
theoretical and estimated values. dDistance from core of the QD to the surface of QSY9 from
experimental data (re) (Figure 4.6).
From Table 4.1, the theoretical estimated maximum distance from the core of the donor to
the surface of acceptor (rt), is calculated taking into account the full extension of the peptide,
an assumed average amino acid length = 3.6 Å and the radius of the QD donor (taken from
product data).
The Förster distance (R0) values of QD-QSY9 were calculated using the Förster formula
(Equation 1.2) where 2 = 2/3, n = 1.4 (which is the assumed refractive index of a biomolecule
in aqueous solution), QD = 40% (taken from QD product data) and the overlap integral of the
donor and calculated from Equation 1.3, and found to be J( ) = 7.4⇥ 10 13 cm3M-1.
The quenching eﬃciency (QE) was calculated from a modified version of Equation 1.4 (Equa-
tion 4.1), which takes into account the number of peptides on the QD surface. A 50:1 peptide:QD
ratio was used (n = 50), along with the theoretical value for R0 and the estimated rt (Table
4.1).
QE =
nR60
nR60 + r
6
(4.1)
The theoretical distance from QD surface to the QSY9 quencher (re), is based on QE taken
from experimental data (Figure 4.6) and rearranging Equation 4.1 (Equation 4.2).
re =

n(1 QE)
QE
  1
6
R0 (4.2)
Experimental data was taken at 50:1 peptide:QD ratio; where QE = 57.2% for the streptavidin-
biotin system and QE = 93.0% for the histag system, using these and the theoretical values for
R0, recould be subequently calculated.
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4.3.1.3 Enzymatic Assay
Following peptide conjugation to the QD surface at a 25:1 MMPD:565-QD ratio for the histag
system and a 80:1 BMMPD:SA-QD ratio for the streptavidin-biotin system, diﬀerent MMP-7
enzyme concentrations were incubated in separate QD reaction mixtures. After allowing the
enzymatic reaction to progress for 3 hours, the PL of individual reactions recorded. For the
histag system only small recovery in PL could be achieved even at high enzyme concentrations
(Figure 4.7).
Figure 4.7: Steady-state photoluminescence spectra following MMP-7 incubation at diﬀerent
concentrations for the histag conjugation system.
This lack of PL recovery for this strategy was thought to be due to the peptide binding
non-specifically to the QD surface or the orientation of the peptide packing on the QD surface
was in someway preventing the enzyme from being able to recognise and cleave the substrate.
This hypothesis is further verified with the fact that the peptide:QD quenching ratio is lower
than the theoretical value calculated (Table 4.1). To prevent any apparent non-specific binding
of the peptide substrate and to make the cleavage substrate more accessible for the enzyme, as
mentioned, the system was redesigned to utilise streptavidin-biotin site specific coupling.
The redesigned system was found to be highly successful with an increase in PL emission
at 565 nm as a function of enzyme concentration (Figures 4.8A and 4.8B) with a detection
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limit of t 50 ng/mL which is in a similar range to previous MMP-7 QD based protease assays
[14, 15]. The overall maximum recovery of PL at 565 nm was around 60% of the PL of SA-QDs
alone at the same concentration. Following the QD-enzymatic reactions over time (Figure 4.8C),
suggests that at the highest enzyme concentration 90% of the final PL was recovered after only
1 hour of enzyme incubation time with the final 10% achieved after 2 hours, reaching a plateau
at 3 hours. In comparison to a lower concentration of enzyme, the PL steadily increased over
time. The enzyme should remain active for several hours so it appears the higher concentration
of enzyme cleaves all accessible peptides on the QD surface within 3 hours but interestingly
never recovers more than 60% of PL. The 40% of unrecovered PL could be a contribution of
many factors, firstly because of the way the peptide stacks on the QD surface not all of the
peptide sequences could be accessible and, following cleavage, there is likely to be short peptide
fragments remaining bound to the QD surface, these short sequences may potentially hinder the
accessibility of the enzyme cleavage sites of the uncleaved BMMPD sequences. Secondly, BSA
is included in the system as it is known to help maintain QD stability in solution and enhance
PL, it has been suggested that BSA forms a complex with QDs attached with various capping
ligands which give rise to an improvement in stability [314, 315, 316, 317]. However, the eﬀect
of BSA on streptavidin functionalised QDs is not studied, streptavidin itself is a protein already
bound to the QD surface forming a complex, so with the high aﬃnity the streptavidin has for the
biotinylated peptide sequence and with the visible quenching behaviour it is unlikely that the
BSA is preferentially interacting with the QD surface in any way. However, BSA is negatively
charged and the BMMP peptide has a slight overall positive charge, so there is potential for the
BSA to be binding some of the peptides in solution which when assembled on the QD surface
may hinder some enzymatic cleavage sites and give rise to only a 60% recovery in PL.
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Figure 4.8: A) Steady-state photoluminescence spectra following MMP-7 incubation at diﬀer-
ent concentrations, B) Concentration-dependent FRET behaviour at diﬀerent MMP-7 enzyme
concentrations and C) Time-resolved evolution of photoluminescence following the addition of
the MMP-7 enzyme for the streptavidin-biotin system.
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4.3.2 Synthesis of Polymer-b-sheet-QD
4.3.2.1 Quantum Dot Immobilisation
SA-QDs were immobilised into the g-PGA-B network by biotin-streptavidin coupling between
the streptavidin conjugated QDs and a biotinylated g-PGA-B network. It was hypothesised
that the approach of allowing the SA-QDs to diﬀuse into the hydrogels network along with the
biotin-streptavidin coupling would provide a high QD doping capacity and help maintain SA-
QDs stability from firm immobilisation. To verify this hypothesis SA-QDs were immobilised into
two diﬀerent hydrogel networks, either functionalised with or without 1% biotin. Following the
incubation with the SA-QDs, it was immediately evident that the SA-QDs diﬀused into the g-
PGA-15% I6b hydrogel completely losing PL (Figure 4.9). In contrast, the SA-QDs immobilised
into the g-PGA-B maintained PL for at least 24 hours and interestingly had a similar PL to
that of QDs in solution at the same concentration and volume. This highlights that the biotin-
streptavidin coupling strategy employed to immobilise QDs into the hydrogel networks is a
viable approach. Determining the exact concentration of SA-QDs immobilised into the hydrogel
network remains a challenge, the most feasible approach would be to use the absorption spectra
and extinction coeﬃcient of the SA-QDs within the g-PGA-QD network, however recording
this spectra with UV-Vis spectroscopy was found to not be trivial, as the dense polymer based
hydrogel is subject to a large background and can mask the SA-QDs absorbance signal.
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Figure 4.9: Photoluminescence spectra of the immobilisation of SA-QDs into diﬀerent hybrid
hydrogel networks.
4.3.3 Characterisation of “Smart” Self-Assembled b-sheet Peptide Nano-Hybrid
Hydrogels
4.3.3.1 Enzymatic assay
Following the immobilisation of the SA-QD MMP-7 sensors into the g-PGA-B network, the
g-PGA-QD hybrid hydrogels were then incubated with the MMP-7 enzyme at a final enzyme
concentration of 5000 ng/mL for 6 hours. Following enzyme incubation, the resultant PL of
the hybrid hydrogels can be viewed in Figure 4.10. There is a distinct increase in PL emission
at 565 nm for the g-PGA-QD hydrogels incubated with MMP-7, verifying that the MMP-7
QD sensors immobilised in the hydrogel network can be recognised and cleaved by the enzyme.
The recovery in PL was ⇡ 3 fold from the quenched state after 6 hours of enzyme incubation.
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However, a steady sloping background line is present with the hydrogels containing the QDs, this
sloping line is usually indicative of the QD emission being scattered, as the hydrogel network
has a higher refractive index compared to that of QDs in solution. Also, due to the nature
of hydrogel network architecture being crosslinked via hydrophobic b-sheet aggregates there is
likely to be diﬀerences in solubility across the bulk structure, increasing the likelihood of QD
emission being scattered. This background scatter can potentially be rectified via background
subtraction before the MMP-7 incubation, however diagnostically using this approach in vivo
may not be as simple and could increase the diagnostic time. At higher enzyme concentrations
the background scatter is not likely to aﬀect the sensitivity of the g-PGA-QD MMP-7 sensors,
but may be significant at lower concentrations having a negative eﬀect of the sensitivity of the
enzymatic assay, but this is yet to be deduced. Overall, from these results there is a huge
potential for these g-PGA-QD hydrogels to be used to sense for MMP-7 activity and for the
platform to act as a template for the sensing of other proteases.
Figure 4.10: Steady-state photoluminescence spectra of g-PGA-QD hybrid hydrogel sensors at
a MMP-7 concentration of 5000 ng/mL.
4.3.3.2 Rheological Studies
The mechanical properties of the g-PGA-QD hydrogels were studied again using oscillatory
shear rheology and using a similar experimental procedure to that of the g-PGA-b-sheet hy-
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drogels previously investigated. It was hypothesised that the immobilisation of QDs into the
hydrogel network via biotin-streptavidin interactions could provide additional crosslinks that
replicate covalent bonds, this could potentially generate a hydrogel network crosslinked by both
pseudo-covalent and the non-covalent b-sheet interactions. The combination of using covalent
and non-covalent crosslinks in hydrogels has been demonstrated to yield hydrogels with highly
stretchable properties [318]. To investigate whether these properties could be inherent to g-
PGA-QD hydrogels, and whether QDs have an eﬀect on the mechanical properties of the hybrid
hydrogels, rheological studies were carried out on the hydrogel networks both with and without
QD immobilised into the network.
In all cases for the g-PGA-QD and g-PGA-B hydrogels, the storage modulus exceeded the
loss modulus, indicating the formation of a gel system. From the frequency sweeps (Figure
4.11A) and strain sweeps (Figure 4.11B) it is evident that their is no diﬀerence in mechanical
properties between the hydrogels with or without QD incorporation. When comparing these
mechanical properties to that of the g-PGA-b-sheet hydrogels in the previous chapter, which
are functionalised with only b-sheet crosslinking domains, it is seen that the g-PGA-QD and g-
PGA-B hydrogels follow a similar trend where the moduli are relatively independent of oscillation
frequency. However, the addition of 1% biotin to the polymer network has a dramatic eﬀect on
the mechanical properties of hybrid hydrogel network. At a similar b-sheet grafting density and
with the same I6b peptide, the storage modulus of the g-PGA-B/g-PGA-QD ⇡ 2 kPa (Figure
4.11C) which is significantly less than that of g-PGA-15% I6b hydrogels where G’ ⇡ 60 kPa.
When comparing the strain sweep of these hydrogels, the g-PGA-15% I6b remained in the linear
elastic region up to strains of 1% with little change in the storage modulus, however a significant
decrease is observed at strains of 15% (Figure 3.9B). In contrast, the g-PGA-B/g-PGA-QD
had a much greater resistance to strain remaining in the linear elastic region up to 10% strain
with a significant decrease by 40% strain (Figure 4.11B). The greater resistance to strain of
the hydrogels containing biotin functionalisation was also quantified by the diﬀerence in failure
strain between the materials, where the failure strain of the g-PGA-B/g-PGA-QD hydrogels
⇡ 80% (Figure 4.11D) compared to ⇡ 20% for that of g-PGA-15% I6b networks. These less stiﬀ
but more flexible hydrogels, can only be attributed to biotin in some way aﬀecting the assembly
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or arrangement of the b-sheet crosslinks in the g-PGA-B/g-PGA-QD hydrogel networks. With
little understanding of molecular architecture and arrangements of any of the hybrid systems,
it is diﬃcult to suggest how the addition of a small amount of biotin conjugated to the polymer
network can aﬀect the mechanical properties in such a dramatic way, especially with no known
knowledge of biotin aﬀecting b-sheet formation. The only known molecule with any resemblance
to biotin that can bind and interact with b-sheet fibrils is ThT which is a special case, with a
high selectivity and aﬃnity for b-sheets, so it is unlikely that biotin can act in a similar way.
If the dramatic change in mechanical properties is a result of biotin somehow preventing the
b-sheet crosslinking propagation into larger domains, this would result in a larger density of
smaller b-sheet crosslinked domains, which in turn would apply less restrictions and rigidity on
the polymer chains, providing a hydrogel with a reduced stiﬀness and more flexible architecture.
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Figure 4.11: A) Frequency sweep at 1% applied strain, B) Strain sweep at an oscillation frequency
of 6.283 rad s-1 C) Storage moduli taken from strain sweeps at 0.1% Strain and oscillation
frequency of 6.283 rad s-1 and D) Failure Strains taken from strain sweeps at the point where
G’ surpasses G’’, for the g-PGA-B and g-PGA-QD hybrid hydrogels.
Being primarily composed of non-covalent b-sheet interactions, the ability for g-PGA-QD
hydrogels to “self-heal” was investigated, and to determine whether the incorporation of both
biotin and QDs into the hydrogels had an eﬀect on the ability of the bonds to reform following
failure. Similarly to the previous chapter, individual sweeps up to 200% strain were performed,
the hydrogels were allowed to recover for 30 minutes and then another strain sweep performed
(Figure 4.12). This process was repeated twice, with the final storage modulus of both g-
PGA-QD and g-PGA-B achieving between 90% and 100% of their original moduli. In terms of
failure strain, there was a similar large recovery which ranged between 80% and 100% for both
hybrid hydrogels, displaying that the immobilisation of QDs into these hydrogel networks had
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no eﬀect on the “self-healing” of these diﬀerent systems. Also, when comparing these values to
the hybrid hydrogels with no biotin functionalisation there is no diﬀerence in recovery of the
original properties.
Figure 4.12: Three repeat strain sweeps from 0.01 – 200% strain at an oscillation frequency of
6.283 rad s-1 with a 30 minute recovery period in between each sweep for the g-PGA-B and
g-PGA-QD hybrid hydrogels.
4.4 Conclusions and Future Work
QD-peptide conjugate biosensors were developed for the sensing of MMP-7, a protease biomarker
for the state of inflammation and immunity. Peptide substrates were rationally designed, to be
conjugated to the QD surface using biotin-streptavidin coupling with a QSY9 dye that eﬀec-
tively quenches the emission of 565nm SA-QDs, and following enzyme mediated cleavage results
in the recovery of the QD emission. The resultant sensors when in solution were found to have
a highly sensitive range of detection, recovering 60% of their PL at the highest enzyme concen-
tration investigated and a limit of detection t 50 ng/mL. The same coupling strategy was then
investigated for the incorporation of SA-QDs into the hybrid hydrogel networks, and found to
provide a high QD doping capacity and maintain SA-QD stability for at least 24 hours whilst
immobilised. Using this strategy, the SA-QD sensors were then immobilised into a biotinylated
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hybrid hydrogel network and found to be able to recover PL following MMP-7 incubation. The
inclusion of QDs into the hybrid hydrogel networks had no eﬀect on the mechanical proper-
ties and “self-healing” of the g-PGA-B hybrid hydrogel networks. However, functionalising the
hybrid-hydrogel networks with 1% biotin produced a diﬀerent set of mechanical properties to
that of the hybrid hydrogels in the previous chapter, having higher failure strains but with a
significant decrease in stiﬀness. In general these nano-hybrid hydrogels are a promising platform
not only for the detection of MMP-7 but the potential to be modified for the sensing of other
proteases of interest.
To further understand the sensitivity and limit of detection for the g-PGA-QD hydrogels, the
hydrogels have to be incubated with a greater range of enzyme concentrations and the subsequent
PL recovery recorded. Also, little is understood about the distribution of the QDs through the
hydrogels, this could be investigated with confocal microscopy and be used to map the PL across
the cross-section of the hydrogels. It is also important to understand the rate of PL recovery at
diﬀerent enzyme concentrations and how the enzymes diﬀuse through the network rather than
focusing entirely on the optical properties of the bulk hydrogels, this again can be potentially
mapped with confocal microscopy. Interestingly, using this technique could give useful additional
information, such as the temporal and spatial mapping of enzyme activity. Having the capability
to recognise these enzymatic properties could be used to investigate biological processes in vitro,
by seeding cells underneath/on top of the hydrogels and then mapping the enzyme diﬀusion
through the three dimensional hydrogel system following the application of biological stimuli.
A number of diﬀerent MMPs are expressed in either diseased or inflamed tissue with dis-
tinctly diﬀerent expression patterns/quantities depending on the cell/tissue type, the disease,
the inflammatory conditions or the tumor itself [307, 309]. To gain a complete understanding
of any of these disease states or processes in vivo, it would require for the multiplexing of dif-
ferent enzymes and biomarkers. One of the prime advantage of using QDs is that they can
be tuned to detect a variety of diﬀerent enzyme activities, attributed with the ability to excite
mixed population at single wavelengths and have been used previously for the multiplexing of
proteases [15, 203]. Since g-PGA-QD hydrogel networks have the capability to immobilise large
concentrations of QDs, it would be possible to incorporate a mixed populations of QD-Peptide
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conjugates that can sense for a range of diﬀerent proteases. With this in mind, one area in which
this information would be invaluable is that of cancer and tumor progression, in which many
MMPs (MMP-1, 2, 3, 7, 8, 9, 12, 13 and 14) are frequently over-expressed and break down ECM
basement proteins, leading to cancer cell invasion and metastasis [309, 308]. The suppression
of MMP activity has in fact been actively used as a method of combating cancer but found
to be unsuccessful for most cancer and tumors types. This suggests that the role MMPs play
in cancer and tumor progression is highly complex. Therefore, g-PGA-QDs hydrogel platforms
loaded with QD sensors that can map and quantify many diﬀerent MMP expressions within
cancerous tissue could give rise to a greater understanding of the roles and expression patterns
MMPs have in diﬀerent cancer and tumor states.
The potential toxicity of QDs is a factor which needs to be considered when designing
systems for in vivo applications. The viability of QDs in vivo has been studied but has lead
to conflicting arguments and more questions regarding their toxicity [319]. As discussed, QDs
are presently composed of a divalent cadmium core, a known nephrotoxin in its ionic form,
which is then surrounded by biologically inert zinc sulfide shell and in the case of our system,
then having a biological streptavidin surface functionalisation, which promotes significantly more
colloidal, chemical, and optical stability. In the short term, having the QDs further encapsulated
into a hydrogel network is not likely to invoke any toxicity in cells but long term, following the
enzymatic breakdown of the hydrogel backbone and the degradation of the biologically inert QD
shell and surface functionalisation makes it hard to predict the potential toxicity QDs may have
in vivo. Following in vivo investigations, there is significant evidence that long term core/shell
CdSe/ZnS QDs with protein or polymer coatings have been found to be nearly biologically inert
in both living cells and animals [183, 320, 321, 185, 322], and only been found to elicit toxic
and inflammatory responses when exposed to extreme conditions or when directly injected into
cells at high concentrations [323, 185]. In the long term, with the progress and development
of polymer conjugated dyes in biological [324, 325] and protease sensing applications [326],
sensors based on these fluorophores could become more biologically viable alternatives to QD
immobilisation in the hybrid hydrogel networks.
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Chapter 5
Conclusions and Future Work
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Through the combination of functional materials, it is possible to generate novel hybrid
materials that have the potential to provide properties far superior to those of the individual
components alone. This thesis has superimposed the advantages of diﬀerent materials, such as
the stimuli responsivity and self-assembly of the peptide components, the tailorability of the
polymer networks and the optical properties of QDs to provide “smart” hydrogels with unique
organisations and properties. These systems have the ability to respond to their mechanical
and biological environment, sensing for biospecific recognition processes through flurorescence
signals.
Chapter 2 described the preparation and characterisation of the g-PGA-H material received.
Being synthesised from bacteria origin it was required to fully characterise and understand the
material properties of g-PGA-H, laying down a foundation for work in the following chapters.
It was determined from analysis of the chemical structure that the received material was pure
and resembled that of the expected native structure. The material was attributed with a high
molecular weight and a low polydispersity. The secondary structure was also probed and found
to resemble that of g-(d)PGA-H stretch, which following molecular dynamic studies, has been
shown to adopt a left-handed helix and undergo a helix-random coil transition when deproto-
nated. To further understand and verify the native secondary structure of g-PGA-H, further
CD experiments could be performed. A thermal unfolding study on g-PGA-H in its un-ionised
form could be used to elucidate any thermal unfolding of the polypeptide chain, this would
further indicate the presence of cooperative folding and the stability of the native conformation
under denaturing conditions. Furthermore, investigations with model oligopeptide sequences
synthesised from repeat d- or l- sub units attempting to mimic the individual d- and l- polypep-
tide stretches, could give valuable information in terms of the properties and recognition of the
suspected g-(d)PGA-H stretch inherent of the g-PGA-H received.
In Chapter 3, taking advantage of the hydrophilicity of g-PGA-H, b-sheet forming peptide
sequences were grafted to the polymer network and through the self-assembly of the b-sheet
sequences, hybrid hydrogels were formed. These hydrogels were attributed with high failure
strains and stiﬀnesses, which could be tuned through diﬀerent compositions. When comparing
these mechanical properties to systems of a similar design and other self-assembled peptide
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hydrogels. The g-PGA-b-sheet hybrid hydrogel’s stiﬀnesses compared well, surpassing that of
other peptide-polymer hybrid hydrogels and having a similar range of stiﬀness to other well
established b-sheet hydrogels. In terms of failure strain, the g-PGA-b-sheet hybrid hydrogels far
surpassed that of any hybrid hydrogel or peptide self-assembled system which tend to fail at 
2%, which is much less than what cells will typically exert on their local environment. They also
were found to have robust properties, resistance to cyclic strain and through the reassembly of
the b-sheet domains could “self-heal” following deformation. Being composed entirely of peptide
bonds, naturally the hybrid hydrogels had good biocompatibility with hMSCs having excellent
cell viability after seven days in culture. One of the principle advantages of this platform,
is that there is scope for further modification of the polymer backbone to be functionalised
with biomolecules, enabling the targeting of certain tissue types and applications. From the
range of stiﬀnesses obtained and the mechanical properties inherent of the hybrid hydrogels,
these systems would be suitable for musculoskeletal tissues, specifically applications in which
repeat loading cycles are required such as cartilage or heart tissue regeneration. With little
understanding about the molecular architecture and arrangement of the b-sheet domains in
these hybrid hydrogels, and how this correlates to the diﬀerences in mechanical properties seen
with diﬀerent compositions. It would be necessary to carry out investigations using SANS, to
illuminate the architecture of the self-assembled b-sheet hybrid hydrogels and then correlate
this relationship to the mechanical properties already determined. To fully understand this
relationship, it is essential to gain insight in to how the b-sheets assemble in these systems both
in terms of the size and spatial density distribution of these domains. To carry out this study,
a variety of hybrid hydrogel networks would be synthesised with normal and deuterated b-sheet
sequences combined with systematic length and grafting density alterations, and then utilise any
contrast-variation to try determine the factors that provide these diﬀerent mechanical properties.
With the capability to further functionalise the hybrid hydrogel platform, Chapter 4 sought
to demonstrate the versatility of this platform by the incorporation of the ability to sense for
MMPs which are known to play fundamental roles in governing cellular processes, and through
their expression patterns and behaviour can be related to disease states. Specifically, the sensing
of MMP-7 was targeted, a protease biomarker for the state of inflammation and immunity.
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Taking inspiration from the success of previous QD-FRET biosensors, a QD based assay for
MMP-7 was designed and characterised, before being incorporated into the hybrid hydrogel
networks using biotin-streptavidin coupling between the polymer-network and QD surface. This
immobilisation strategy was demonstrated to help maintain QD stability and PL, and provide
a high QD doping capacity. Once immobilised the QD sensors were found to be able to sense
for MMP-7 activity, highlighting the potential of this platform to be used in future sensing
applications. This platform has the potential to be further developed for both in vivo and in
vitro applications, with the ability to map enzyme activity temporally and spatially via confocal
imaging which could be used to gain a great understanding of biological processes in vitro. A
number of diﬀerent MMPs are expressed in diseased or inflamed tissue with distinctly diﬀerent
expression patterns and quantities, with their diﬀerent roles being a highly complex process.
With this in mind the g-PGA-QD hydrogel networks have the potential to be developed for
the multiplexing of various enzymes and proteases, this could be used as a powerful tool to
gain invaluable insight into the disease state of diﬀerent cancers and tumors in vivo. However,
a huge amount of diﬀerent proteases are expressed in these disease states and each with their
own diﬀerent expression patterns, so to gain the complete picture of these processes and the
roles involved, may be incredibly challenging. Also, with QDs having questionable long term in
vivo cytotoxicity, the future of these platforms maybe will lie with the development of sensing
applications using polymer conjugated dyes, which when incorporated into the hydrogel network
may oﬀer a more biologically viable alternative.
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